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ABSTRACT

Adrenal glucocorticoids are essential for the developm ent of all forms
of experimental obesity. In the o b ese {fa/fa) Zucker rats, adrenalectom y
prevents the further developm ent of obesity, and glucocorticoid replacem ent
restores the o b ese phenotype. We have hypothesized that this dependence
on glucocorticoids is due to differences in transcriptional regulation of a
group of g e n es that are normally regulated by glucocorticoids. We have
ch o sen to study the DNA fragm ents from the upstream region of the malic
enzym e (ME) gene, which is positively regulated by glucocorticoids. Hepatic
nuclear extracts from lean and o b e se Zucker rats were used in band shift
studies to look for differences in binding of nuclear proteins to the DNA. All of
the upstream DNA fragm ents bind more o b ese nuclear protein than lean
nuclear protein. Adrenalectomy d e c re a se s the am ount of o b e se nuclear
protein bound to the 222 bp fragment to the sam e level a s the lean nuclear
protein. Treatm ent of the nuclear proteins with alkaline phosphatase altered
gel retardation patterns and suggests that phosphorylation state of the
nuclear proteins is important for DNA binding. The hepatic nuclear extracts
w ere also analyzed in 2- dimensional SDS PAGE. Two proteins were
p resent in lean nuclear extract but ab sen t from o b e se nuclear extract. The
proteins were N-terminal blocked and could not be used for N-terminal
sequencing. T h ese data su g g est that changes in nuclear proteins may be
involved in the altered transcription of this glucocorticoid regulated gene.
Our study sug g ests that differences betw een lean and o b ese Zucker
rats in nuclear proteins binding to the upstream regions of ME gen e may
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reflect changes in phosphorylation state and differential effects of
glucocorticoids.

REVIEW OF LITERATURE

Obesity affects more hum ans than any other health problem. O ne
fourth of the United S tates adult population w as reported to be more than
20% above normal weight in 1981 (1). After a decade, more than three in ten
adult Am ericans now fall in this category (2), and m any of th ese are grossly
o b e se (3). Indeed, epidemiological studies showed that the prevalence of
obesity is increasing from generation to generation (4).
Although the m echanism s leading to obesity status are complex and
diverse, familial studies clearly indicate the influence of g e n es on metabolic
regulation (5-7). In an adoption study of human obesity recently performed
by Stunkard et al. (5) with 540 adult adoptees, a strong relation betw een the
weight class of the adoptees and the body-m ass index of their biologic
parents w as observed, w hereas there w as no relation betw een the weight
class of the ad o p tees and the body-m ass index of their adoptive parents.
Cumulative distributions of the body-m ass index of parents showed similar
results. This indicates that genetic influences have an important role in
determining human fatness in adults, w hereas the family environment alone
h as no apparent effect (5). To date, there are several g e n es associated
and/or linked with hum an obesity (8).

Animal models of genetic obesity
Animal m odels of genetic obesity, especially single-gene mutation
o b e se animals, are particularly useful for the study of obesity. They can be
m aintained in standard inbred backgrounds, and appropriate matings of the
anim als can give rise to predictable num bers of unaffected and affected
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animals, all of which have the sam e genetic background, differing only by the
p resen ce of a single mutant gene or a small region of the chrom osom e
containing the m utant g en e (9).
In 1905, genetically determined obesity w as first described in the
yellow m ouse by L. Cuenot (10). Since then, animal m odels have been used
to study the metabolic and behavioral changes that lead to obesity. The
results have been applied to the human obesity caused by single gene
m utations (8).
More than five m ouse mutations and at least one rat mutation causing
obesity have been intensively studied and are encoded on five different
m ouse and rat chrom osom es (8). T hese rodent obesity g e n es code for
regions that have human homologous equivalents, which are located on five
different hum an chrom osom es (Table 1) (11). T hese animal m odels cover a
wide range of changes in the manifestation of obesity coupled with varying
d e g re es of diabetes and provide investigators m odels with which to advance
our understanding of the c au se s and developm ent of obesity-diabetes
conditions (9). To date, three of the m ouse g en es (a, ob and fat) have been
cloned (12-14).

The yellow mouse
The agouti locus (a) is located on m ouse chrom osom e 2. It
differentially regulates the synthesis of eumelanin (black or brown) and
phaeom elanin (yellow) pigment granules by the m elanocytes within the hair
follicle (15). Since the original description of the yellow (4y) m ouse (10), a
num ber of additional alleles have appeared at the agouti locus (12, 16).
Different combinations of alleles result in an array of different phenotypes,

3

Table 1. Possible synteny between rodent obesity genes and human
chromosome regions
Locus
D iabetes (db)*
O b ese (ob)*
Tubby (tub)*
Fat (fat)*
Yellow (Ay)*
Zucker (fa)**

Transmission
R ecessive
R ecessive
R ecessive
R ecessive
Dominant
R ecessive

Rodent
chrom osom e
4
6
7
8
2
5

Adapted from references 1 1 ,1 5 and 17.
*, from mice.
**, from rats.

Human
hom ologous region
1p31-pter
7q31
11 p15.1
16q22-24
20q11.2
1p31-pter
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ranging from subtle changes in coat color from the wild type, to drastic
c h an g es in the distribution of pigmentation in different regions of the animal,
especially acro ss the dorso-ventral surface. The lethal yellow (Ay) m ouse has
an all-yellow phenotype in the heterozygous condition (15, 18), the black-and
tan (a*) m ouse h a s an all-black dorsum and an all-yellow ventrum (19), while
the nonagouti (a) m ouse has a predominantly black phenotype (16) and
extrem e nonagouti (ae) m ouse has a completely black phenotype (20). Silver
and coworkers did a series of experim ents to dem onstrate that the a locus
functions within the microenvironment of the hair follicle (16, 21-24).
The hom ozygous dominant yellow mutation c a u se s death in very
early sta g es in development, around the time of implantation possibly due to
a delay in giant cell differentiation, preventing the embryo’s attachm ent to the
endometrial cells that line the uterus (25-28).
Pleiotropic effects of the dominant agouti mutations include
pronounced pbesity (29-32) and increased susceptibility to diabetes (33).
Heston and coworkers w ere able to dem onstrate that th e lethal yellow
heterozygotes have a tendency to develop a variety of spontaneous and
induced neoplasm s including pulmonary tumors, mammary-gland tumors,
and hepatom as (34-38). In addition, it w as reported that the lethal yellow
heterozygotes exhibit a system ic stimulation in body growth and reduced
fertility in fem ales (39).
A breakthrough cam e when a radiation-induced inversion mutation
which contains DNA breakpoints in the limb deformity (Id) and agouti loci
w as reported in 1990 (40). A DNA probe from the Id region w as used to
successfully clone a region of DNA that m aps to the agouti locus (40). Two
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y ears later, the agouti gene w as cloned and characterized (12). It w as shown
to en co d e a 131 amino acid protein. The gen e is normally expressed
predominantly in neonatal skin (12). The dominant yellow (Ay) mutation is
associated with translocation and overexpression of the g en e in m ost tissues
of the adult m ouse (12, 18). In 1994, a human homologue of the agouti gen e
w as m apped to chrom osom e 20q11.2 and cloned. The agouti g en e and the
protein that it enco d es are now under extensive study. A recent report
show ed that the agouti protein is a high-affinity antagonist of the melanocytestimulating hormone (MSH) receptor and blocks a-MSH stimulation of
adenylyl cyclase, which is the effector through which a-MSH induces
eum elanin synthesis (41). It w as reasoned that the obesity caused by
ectopic expression of agouti in the lethal yellow (Ay) m ouse may be due to
the inhibition of melanocortin receptor(s) outside the hair follicle (41).

The obese and diabetes mice
The ob m ouse w as first described by Ingalls et al. in 1950 (42). It
inherits its obesity a s an autosom al recessive mutation on chrom osom e 6
(43). The earliest detectable change in preobese ob/ob mice is an
impairment in therm ogenesis (44-45). During the dynamic p h ase of the
obesity, hyperinsulinemia and hyperphagia increase with the progressive
ap p earan ce of glucose intolerance, fasting hyperglycemia, and resistance to
exogenous insulin (46). However the obesity of ob/ob mice is not dependent
on the hyperphagia (47-49).
The diabetes (dbfdb) mutation on chrom osom e 4 (43) originally aro se
on the C57BL/KsJ background. It is also an autosom al recessive gene. The
ob and db mutation c au se similar if not identical diabetes-obesity syndrom es
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when maintained in the sam e inbred background (43). The only comparative
d ata that distinguish th e se two mutations from each other are the results of
the well-known parabiosis experim ents (cross circulation studies) performed
by Colem an (50-51). In th ese experim ents capillary an astom oses
(exchanging 2-3% of cardiac output) were m ade betw een three se ts of mice.
In the first se t (ob to wiid-type), it w as found that o b ese mice lost weight,
indicating that ob is deficient for a circulation factor that su p p re sses appetite.
In the second se t (db to wild-type), it w as noted that the normal mice starved
to death while the db m ouse survived, suggesting that the db m ouse is
resistant to a circulating appetite suppressant and it secondarily
overproduces that factor. The third se t used ob and db mice and it w as found
that the ob mice starved to death, suggesting that db mice are resistant to
th e sa m e factor that is ab sen t or defect in ob mice (11).
With the developm ent of the techniques of positional cloning, the
m ouse ob g en e and its hum an homologue w ere recently cloned by J. M.
Friedm an's group (13). First, in 1991, they positioned ob on m ouse
chrom osom e 6 and m apped the ob gene betw een two restriction-fragment
length polymorphism (RFLP) markers, D6Rck13 and Pax4 (52-54). Then
they cloned the DNA in the region of Pax4 and D6Rck13, using both probes
to start the construction of a physical map in the region of ob (13). Finally,
using the method of exon trapping, they were able to isolate g e n e s from a
650-kb interval that w as indicated in previous genetic studies to contain the
ob g en e (13, 55). By screening putative exons for the p resence of
corresponding RNA from a variety of tissues using northern blots and
reverse-transcription PCR, they found 6 genes, one of which, 2G7, w as
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hybridized to a northern blot of m ouse tissues. A 4.5-kb RNA that exists only
in white adipose tissue w as detected and the 2G7 w as used to screen a
m ouse adipose tissue cDNA library and the isolated clones sequenced (13).
Their results show ed a 167 amino acid open reading fram e followed by a
long 3'-untranslated sequence (13). The predicted amino acid seq u en ce is
84% identical betw een human and m ouse and has som e features of a
secreted protein (13). They suggested that the ob gen e product m ay function
a s part of a signaling pathway from adipose tissue that acts to regulate the
size of the body fat depot. In a severely o b ese ob/ob m ouse line studied by
Zhang et al., a no n sen se mutation in codon 105 of the m ouse g en e has
occurred and it ex p resses a 20-fold increase in adipose tissue ob mRNA.
Another ob mutant m ouse strain studied by the sam e group d o e s not show
any evidence for the expression of the gene (13), indicating the importance
of the ob product in the m aintenance of the non-obese status.
Recently, three articles reported the in vivo studies of the effect of the
so called OB protein in mice, which were carried out by three independent
research groups (56-58). In th ese studies, the recombinant m ouse OB
protein w as expressed in bacterial system s and purified to nearly
homogeneity. Administration of the OB protein intraperitoneally (56-58),
intravenously, or intracerebroventricularly (58) all resulted in a rem arkable
d e crea se in the body weight of ob/ob mice com pared with that of the lean
animals. T hese results prove that the OB protein is the "circulating appetite
suppressant" suggested by Coleman in his parabiosis experim ents
mentioned above (50-51). The most obvious effect of the OB protein is the
reduction of the anim al's appetites. But food intake alone d o e s not seem to
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account for the overall weight loss induced by the OB protein b e ca u se the
OB-treated mice lost 50% more weight than the untreated mice even when
they w ere on the sam e diets (57). Pelleymounter et al. w ere able to show
that b esides the reduction of the anim als’ appetites, the OB-treated mice
increased their total activity to the level of the lean anim als and the metabolic
indices in them were normalized (56). T hese findings indicate that the OB
protein also increases the energy expenditure in th ese animals. Furthermore,
also consistent with Colem an's parabiosis experim ents, the OB protein has
no effect on dbldb mice, which seem to have a defect in the receptor for the
OB protein (57-58). The OB receptor se em s to exist at least in the brain
b e ca u se direct injection of small d o se of OB protein into the brains of mice
resulted in similar effects that w ere cau sed by much higher d o se s when
given intravenously (58). However, w hether the OB receptor may exist
elsew here and what exactly happens after the binding of the OB protein to
its receptor remain to be elucidated.

The fat and tubbv mice
The fat and tub mice were first described by Coleman and Eicher in
1990 (9), although they w ere originally found a s spontaneous mutations at
The Jackson Laboratory in early 1970's. Breeding tests indicated that th ese
obesity conditions w ere both caused by autosom al recessive mutations. The
developm ent of obesity syndrom e in tubby and fat is slow com pared to the
phenotypically similar ob and db mice. Problem s in glucose hom eostasis are
mild and only transient. Hyperglycemia is only se en in hom ozygous fat m ales
betw een the a g e s of 7-11 w eeks w hereas fat fem ales and tubby m utants of
both se x es remain normoglycemic or slightly hypoglycemic (9). Both of the
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hom ozygous tub and fat mice are infertile, but not sterile, and can produce
litters when the anim als are m ated before severe obesity develops (5-8
w eeks for fat/fat and 12 w eeks for tub/tub).
Although mice with a genotype of fat/fat develop obesity at a slower
rate than hom ozygous ob or db mice, they still can becom e two (male) or
three (female) tim es heavier than wild-type litter m ates (9, 14). Most of the
ex ce ss weight in the fat m utants results from increased weight of body fat
that distributes to fat stores throughout the body. This is different from the
pear-shaped body conformation caused by the confinement of body fat to
the axial and inguinal regions in the ob and db mutants.
The obesity syndrom es in the fat/fat rats include increased rate of
weight gain, high blood sugar concentration, hyperproinsulinemia, and
abnorm al pancreatic morphology. Interestingly, th ese conditions remain mild
and diabetes w as not present when the fat/fat mutation w as placed on the
BKs inbred background. This is in contrast with the chan g es from mild to
sev ere diabetes observed when either the ob or db mutation w as placed on
the BKs inbred background.
The m ost striking feature of fat mutants is the pronounced
hyperinsulinemia (14) which becom es apparent a s early a s 4 w eeks of age,
when obesity is not detectable (9). This symptom w as observed in both the
BKs background and the HRS/J background, in which the fat m utant w as
originally identified.
In 1994, the fat mutation w as m apped to m ouse chrom osom e 8 by
Paigen and Coleman (59). In 1995, Naggert et al. w ere able to link the fat
gene to th e vicinity of carboxypeptidase E (Cpe or Cph-1) by screening for
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recom binants in progeny of +!fat matings (14). C pe is an exopeptidase
involved in the processing of prohorm ones including proinsulin (60). Naggert
et al. show ed that the hyperinsulinemia in fatlfat mice is a consequence of
abnorm al Cpe expression which results in abnormal proinsuiin processing.
They also dem onstrated that the mutant Cpe g en e contains a single
m issen se mutation (Ser202Pro), which abolishes CPE enzymatic activity
w hen expressed in a baculovirus system . All th e se d ata strongly support that
fat is a mutation at the Cpe locus. But it is still not known w hether that fat
phenotype is a direct consequence of faulty processing of proinsulin or som e
other horm one b ecau se fat mice are not always hyperglycemic. Since the
expression of Cpe is not limited to pancreatic islets, Naggert et al. proposed
that the developm ent of obesity may be a more direct consequence of
abnorm al processing of som e other neuroendocrine prohorm one (e.g.
neuropeptide V, enkephalins, proopiomelanocortin and oxytocinvasopressin), and not simply insulin (14). The fact that the fatlfat mice are
functionally infertile also supports the suggestion that there are defects in the
neuroendocrine axis.
Tubby mice are phenotypically very similar to fat mice except for
slower developm ent of obesity (The phenotype cannot be recognized until 912 w eeks of age) and the existence of sexual dimorphisms with respect to
rate of weight gain, plasm a insulin concentration, and pancreatic morphology
in tub mice. The average weight at 24 weeks is 46.4±0.9 g in tub/tub m ales
com pared to only 38.6±1.1 g in fem ales. Both se x es develop mild
hyperglycemia associated with hyperinsulinemia. Histological examination of
th e p an creas show ed relatively normal islet morphology in both se x es when
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com pared to normal littermates. Som e enlargem ent of the islets occurred at
12 w eeks of ag e in m ales and 24 w eeks in fem ales. Degranulation of the p
cells w as seen only in the late stages, indicating that insulin synthesis and
secretion in tub/tub mice can be sustained at levels sufficient to maintain
n e ar normal p-cell granulation (9). The tub gene h as been located on
chrom osom e 7 near the Hbb (hemoglobin beta-chain complex) locus and
related studies are still underway.

The Zucker rats
The o b ese Zucker {fa/fa) rat w as first described in 1961 a s a
sp o n taneous mutation in a cross betw een the Merck Stock M and Sherm an
rats (61). The o b ese phenotype is transmitted a s an autosom al recessive
trait and the homozygous animals suffer the co nsequences of genetic
obesity, which closely resem bles human juvenile onset obesity (62-64).
Zucker fatty rats e a t large m eals com pared with the food intake of
their lean litter-mates (47-55, 65-69). However hyperphagia is not the only
responsible factor b ecau se pair-feeding o b ese rats with lean o n es d o e s not
prevent the developm ent of the obesity (69-70) and food restriction before
weaning failed to stop the hypertrophy and hyperplasia of adipose tissue
d epots (71).
The concentration of both circulating cholesterol and triglycerides in
th e o b e se Zucker rats is very high (61, 69, 72). This hyperlipidemia is
characterized by increases in all lipoprotein c la sses with marked elevations
in very low density lipoproteins (VLDL) (73). The pathogenesis of the
hyperlipidemia in o b e se Zucker rats is not completely understood. It w as
su g g ested that increased production of lipoproteins is the major c au se (74).
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In the liver of o b e se Zucker rats there is an increase in lipogenesis with a
concom itant d ecrease in fatty acid oxidation (75-76). The activity of
lipoprotein lipase, which hydrolyzes plasm a triglycerides, is elevated in white
adipose tissue and reduced in brown adipose and m uscle a s early a s the
first or second week of life (77-78).
Hypertrophy and hyperplasia of the p-cells in o b ese Zucker rats
results in a major hypersecretion of insulin. The insulin levels in o b ese
Zucker rats are above those of the lean rats a s early a s 3 w eeks of ag e (65,
79). Fasting insulin levels were increased by 10-fold in fa/fa rats com pared
with lean Zucker rats (80). Postprandial insuHn levels w ere even higher in
o b e se Zucker rats (69). Despite this increase in plasm a insulin levels, o b ese
Zucker rats had higher plasm a glucose levels than lean Zucker rats (80).
This is b e cau se o b ese Zucker rats also develop insulin resistance, which has
been well docum ented (69, 74, 80-83). The life span of o b e se Zucker rats
can be divided into two sta g es based on insulin resistance. In the first stage,
there is a pancreatic oversecretion of insulin with a reduced hepatic
clearance of the hormone (84), while a general state of insulin resistance is
p resent in the later stag e (69). Both in vitro and in vivo experim ents have
dem onstrated the insulin status in o b e se Zucker rats. D ecreased insulin
binding to plasm a m em branes has been observed in isolated liver, muscle
and adipose cells (69), and it has been shown that hepatic glucose
production in o b e se Zucker rats w as not inhibited by insulin, indicating that
gluconeogenesis and lipogenesis are insulin resistant in liver (69). Insulin
resistance w as initially thought to be caused by decreased insulin binding
b e ca u se of the observation of decreased insulin receptor num bers in the

13

o b e se Zucker rats (85). It w as later realized that this decreased binding w as
not sufficient to explain the overall state of resistance b ecau se it h as been
shown that food intake restriction or pair-feeding can restore the levels of
insulin to normal in adult rats (76). It w as reported that insulin-stimulated
protein kinase activity, a postreceptor event, w as decreased in both heart
and liver tissue from o b e se Zucker rats (86). T hese studies suggest that
insulin resistance in o b ese Zucker rats involves both receptor and
postreceptor abnormalities a s will be discussed later.
The therm ogenic capacity of brown adipose tissue is significantly
reduced in o b ese mice or rats when com pared with that in lean ones
although the o b ese ones exhibit increased brown fat m ass (87-88). It h as
been shown that the brown fat metabolism of the o b ese Zucker rats d o e s not
increase a s much in response to maximum d o se s of the beta agonist
isoproterenol a s in the lean rats (89) and the maximum activities of several
brown fat oxidative enzym es are lower in o b ese Zucker rats (78).
G.

E. Truett and coworkers m apped fa betw een two molecular

m arkers, Ifa and Glut-1, which also flank db on m ouse chrom osom e 4 and
are located on rat chrom osom e 5. Their results placed fa on rat chrom osom e
5 and suggested that db and fa are mutations in hom ologous g e n es (90).
Both the fa and db gen e appear to have a human counterpart on
chrom osom e 1p31 (29).
In the experim ents carried out in 1981 by R. B. S. Harris using tubefeeding induced o b ese rats (91), the obese rats appeared to produce a
blood-borne factor that h as a very mild effect on food intake and caused the
selective depletion of body fat, indicating that this factor is probably anti-
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lipogenic. The parabiosis experim ents betw een falfa and wild-type rats
performed later by the sam e group (66) show ed that the fatty rat exerts the
sam e effect a s do db mice. Interestingly, it has been shown that ventral
medial hypothalam us (VMH) lesioned rats also behave similarly to db mice
and fa rats in parabiosis experim ents (67). All th ese results indicate that the
blood-borne factor in rats is very likely the rat homologue of m ouse ob g en e
product and this factor is not functioning properly in th e se falfa rats. Not
surprisingly, it w as recently found that the ob mRNA level in fa/fa rats w as 10
fold higher than in their lean litter m ates (Abstract in press, X. Lin and D. A.
York).

Glucocorticoids and obesity
Since the first description and isolation of glucocorticoid horm ones
more than half a century ago (92), their roles in development, metabolism
and the response to stress have been intensively studied.
Glucocorticoids are secreted from the zona fasciculata of the adrenal
cortex after being synthesized from cholesterol by a series of reactions (93).
The major glucocorticoid in man is cortisol and in rat, corticosterone. About
95% of the glucocorticoids in the circulation are bound to plasm a proteins,
primarily corticosteroid-binding globulin. The secretion of glucocorticoids is
regulated by adrenocorticotropic hormone (ACTH, corticotropin). ACTH is
produced by the pituitary gland and is regulated by corticotropin releasing
factor (CRF), which is in turn produced by the hypothalamus. By feedback
regulation, the glucocorticoids inhibit ACTH production and secretion,
probably at both the hypothalamic and pituitary levels (94). B ecause the
glucocorticoids are lipid-soluble, they readily cross the plasm a m em brane
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and combine with the glucocorticoid receptor, the first steroid receptor
discovered (95).
As signals to cope with stress, glucocorticoids have effects on a wide
range of tissues and metabolic pathways, involving stimulation of many
physiologic, metabolic, cardiovascular, and other functions (93). The
metabolic effects of glucocorticoids lead to the propensity of hyperglycemia
and nitrogen wasting. In the liver, the glucocorticoids increase glucose
production b e cau se of the induction of gluconeogenic enzym es, permissive
effects on the actions of glucagon and epinephrine, and increased
availability of substrate. Glucocorticoids induce breakdown of both protein
and nucleic acid and inhibit protein synthesis in muscle, making m uscle the
major source of amino acids. In adipose tissue the glucocorticoids stimulate
lipolysis, promote the lipolytic effect of epinephrine, and increase the
production of lactic acid. Glucocorticoids and insulin generally have
antagonistic effects w hereas the actions of a num ber of other horm ones may
be amplified by glucocorticoids. It has been suggested that glucocorticoids
m ay be required by the adrenal medulla to produce epinephrine, which has p
-adrenergic activity (93).
Glucocorticoids have an important function in regulating body weight
(93). Both acute and chronic administration of corticosterone can induce
obesity in normal mice (92). The cau se for this response is probably
increased food consumption, and circulating insulin a s well a s the d e crea se
of therm ogenesis in brown adipose tissue (96-98).
Circulating glucocorticoid levels are increased in the obtob and dbldb
mice (99-100). However most studies have found normal levels of
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corticosterone in the o b e se Zucker (fatty) rat (65, 101-105), although som e
studies have shown marginally increased circulating levels of corticosterone
(101-102). Studies in rats with VMH lesions also showed normal
corticosterone concentration (27). T hese results indicate, a s will be
d iscussed below, that there is an increased responsiveness to
glucocorticoids in the experimental animal obesities (46, 106).
The developm ent of all the experimental obesity models can be
prevented or suppressed by adrenalectom y and restored by replacem ents of
glucocorticoids (46). It occurs in hypothalamic obesity after VMH and PVN
lesions (107), in dietary obesity after feeding high fat diets to certain strains
of rat (108), in older rats that becom e o b ese on "cafeteria" diets (109) and in
the genetic o b ese anim als such a s obfob (98, 110-113), dbldb (114), and
Ay/a (115) mice and falfa rat (116-120).
An increased sensitivity and responsiveness to glucocorticoids
ap p ears to be characteristic of the experimental animal obesities (46, 106).
This altered responsiveness and sensitivity were widely observed in the
studies with replacem ent d o se s of glucocorticoids given to adrenalectom ized
lean and o b ese anim als (110, 119 ,121-122).
Most of the abnormalities that are associated with the developm ent of
obesity in animal models, especially those that are involved in carbohydrate
and protein metabolism, have been shown to be influenced by the
restorative effects of adrenalectomy. T hese abnormalities include body
weight (88,123), fat deposition (124), fat cell size (120), m uscle weight
(111), energetic efficiency (88,123-124), food intake (88,125), m eal pattern
(125), thyroid function (112), islet cell distribution (114), insulin concentration
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(115, 124), insulin response (113), glucose tolerance (96), protein synthesis
(126), lipoprotein lipase (115), lipogenesis (117), brown adipose tissue
function (127), body tem perature (128), mRNA level of malic enzym e and
GAPDH (118), etc. Although the falfa rat may have marginally increased
circulating levels of corticosterone (101-102) this cannot account for the
glucocorticoid d ep en d en ce since replacem ent of adrenalectom ized o b e se
rats with glucocorticoids will restore obesity w hereas identical treatm ent of
adrenalectom ized lean rats has no such effect.
Although adrenalectom y has a wide-ranging restorative effects a s
mentioned above, it d o es not restore body composition and serum insulin
levels precisely to those se en in lean rats b ecause som e of the changes are
already irreversible. This is well dem onstrated by observation of serum
insulin. The serum insulin falls to low levels after adrenalectom y (112) but
still rem ains slightly elevated when com pared to the lean animals. This h as
been reasoned to result from the existing hyperplasia and hypertrophy of the
islet tissue b e ca u se serum insulin levels of the w eaned fa/fa rat have been
found to stay at the lean levels if the adrenalectom y is performed prior to
weaning (117). The reduction of serum insulin level in the o b e se anim als
after adrenalectom y probably results from a decreased activity of the
parasym pathetic nervous system and the enteroinsular axis and an
increased activity of the sym pathetic nervous system that links to the
p an creas (117). Therefore it seem s that adrenalectom y normalizes
autonom ic balance, islet anatom y (114), and glucose metabolism (96, 129).
In a study performed by Langley and York (130), young o b ese falfa
rats w ere treated with RU-38486, a type II glucocorticoid receptor antagonist,
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for 15 days. Analysis of body composition changes show ed that RU-38486
effectively reversed the obesity. It stopped fat deposition in o b ese rats but
increased protein deposition to the level of lean-vehicle rats. RU-38486 also
prevented the developm ent of hyperphagia and reduced gross energetic
efficiency in the o b ese rats but had little effect on lean rats. The study also
show ed that mitochondrial GDP binding w as increased in brown adipose
tissue of o b ese rats but w as reduced in lean rats by RU-38486 treatm ent.
RU-38486 also reduced the elevated activity of hippocampal
glycerophosphate dehydrogenase, a glucocorticoid-responsive enzym e, of
o b e se rats to the level of lean rats. Their results suggested that abnormal
activity of glucocorticoid receptors or abnormal cellular responsiveness to
corticosterone receptor complexes may be important in the developm ent of
obesity in the falfa rat.
A transgenic m ouse with impaired corticosteroid receptor function w as
created by partially knocking out gene expression with type II Glucocorticoid
receptor (5q31-32) antisense RNA (131). The transgenic anim als had
increased fat deposition and a body m ass that by about 6 months of ag e w as
twice a s large a s that of controls. An elevated body fat content w as observed
despite the fact that transgenic animals ate about 15% less than the normal
mice. Increased serum concentrations of corticosterone and ACTH, a similar
feature se en in o b ese fa/fa rats, were also seen in th ese animals. T hese
results clearly indicated the important role that glucocorticoids play in the
developm ent of obesity. However, they argue against all other experimental
data, which show ed the positive effect of the glucocorticoid receptor in the
developm ent of obesity, although the m echanism is still unknown.
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Insulin and the development of obesity
Discovered over 70 years ago, insulin is the m ost important secretory
product of the pancreatic beta cell and plays a central role in the regulation
of m any key metabolic p ro cesses (132). Hyperinsulinism, insulin resistance,
and d ecreased num ber of insulin receptors are characteristic of obesity in
both hum an and experimental animals (133). As h as been mentioned above,
fasting insulin levels w ere increased by a s much a s 10-fold in o b e se Zucker
rats com pared with lean Zucker rats (80). Postprandial insulin levels w ere
even higher in o b ese Zucker rats.
In contrast to glucocorticoids, which are steroid hormones, insulin is a
polypeptide horm one (134) produced by the p-cells of the pancreas in
resp o n se to nutritional, neural and endocrine stimuli. The most important
physiological regulator of insulin release is glucose (135). Amino acids,
especially the essential amino acids leucine, arginine, and lysine, have been
shown to stimulate insulin release in the a b sen c e of glucose (136). However,
various lipids and their m etabolites appear to have only minor effects on
insulin release (137). The pancreatic hormone glucagon has a stimulatory
effect on insulin release (138), while som atostatin inhibits insulin release
(139). O ther horm ones, such a s glucocorticoids, prolactin, growth hormone,
placental lactogen, and the sex hormones, have also been found to stimulate
insulin secretion (140). It w as reported that the adrenergic neurotransm itters,
norepinephrine and epinephrine, suppress insulin release and
parasym pathom im etic agents stimulate insulin release (141). In vivo studies
of beta-cell secretory function have dem onstrated that insulin is released in a
pulsatile m anner (142).
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The major site of insulin metabolism is liver (143), which extracts half
of the insulin delivered to it. The first step in degradation of the hormone
ap p ears to be binding to receptors on the hepatocyte surface. After insulin is
internalized, at least som e of them has been shown to serve a s the substrate
for degradation (143). Other sites of insulin metabolism include kidney,
adipose tissue, blood cells, and placenta (144).
Although insulin exerts regulatory or growth effects on almost every
cell of th e body, the m ost important tissues for insulin action are muscle,
liver, and adipose tissue (132). Insulin activates the transport system s and
enzym es involved in utilization and storage of glucose, amino acids, and
fatty acids, and inhibits gluconeogenesis, glycogenolysis, lipolysis, and
protein breakdown (145).
Insulin released into blood binds to the a subunit of its receptor in its
target tissues and activates the receptor tyrosine kinase. This, in turn,
initiates the cellular processes that regulate organismal glucose hom eostasis
by activation of existing transport system s, recruitment of intracellular
proteins such a s glucose transporters (GLUT-4) from intracellular storage
vesicles to the plasm a m em brane (146-147), and covalent modification of
pre-existing enzym es by phosphorylation or dephosphorylation such a s
pyruvate dehydrogenase, acetyl-CoA carboxylase, triacylglycerol lipase,
phosphorylase kinase, and glycogen synthase and phosphorylase (148). On
a slightly slower time frame (i.e., several minutes to a few hours) than for
nutrient transport, insulin also regulates transcription of specific g e n es and
new protein synthesis. It has been known that insulin stim ulates the
synthesis of pyruvate kinase, malic enzym e, and glucokinase and inhibits
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that of phosphoenolpyruvate carboxy kinase (PEPCK), carbamoyl
phosphate synthetase I, and fructose-1,6-bisphosphatase (145, 149).
P h o sp h o ry la tio n of th e g lu co co rtico id re c e p to r a n d insulin re c e p to r
Although the discovery of protein phosphorylation a s a m echanism by
which extracellular signals regulate cellular functions w as dated a s early a s
the late 1950s (150), it has been only a few years since protein
phosphorylation/dephosphorylation began to b e recognized a s a critical
m echanism in signal transduction used by num erous growth factors and
horm ones, including glucocorticoids and insulin (151-152). The
phosphorylation of nuclear proteins h as been widely observed in the
regulation of g en e transcription (153). The C-terminal domain (CTD) of the
large subunit of RNA polym erase II h as multiple repeats that can be
phosphorylated at multiple sites (154). It has been shown that the
hyperphosphorylated form is the major form in transcribing polym erase II
com plexes (155) and that only the un-phosphorylated form of polym erase II
can en ter the initiation pathway. It w as proposed that phosphorylation of this
subunit m ay be needed to trigger conversion of an initiation complex into an
elongation complex (156) although the true nature of the CTD protein kinase
is unknown. Pulverer et al. w ere able to dem onstrate that the DNA binding of
c-Jun is negatively regulated at one se t of sites by phosphorylation and
phosphorylation at another se t of sites increases transactivation activity
(157). Phosphorylation is also reported to be able to m odulate nuclear
translocation and other properties of transcription factors such a s the
interaction betw een factors when bound to neighboring sites in a prom oter or
en h an cer (158). However, the identification of transcription factors which
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direct g en e transcription a s a result of posttranslational modification has
been difficult to dem onstrate.
There have been reports of changes in the activity of a protein
p h o sp h atase (glycogen synthase phosphatase) (159-160) in hepatocytes
from o b e se Zucker rats. Furthermore, M. D. Houslay’s studies show ed that
ligands which enhanced Gr 2 phosphorylation in intact hepatocytes from lean
Zucker rats failed to do so in hepatocytes from o b e se animals. They
su g g ested that this defect in guanine-nucleotide-m ediated “G| function” se en
in o b ese Zucker rats m ay be due to an inactivating phosphorylation of a G r 2
(161).

Glucocorticoid receptor
Like other steroid receptors, the glucocorticoid receptor consists of a
ligand binding domain, a DNA binding domain, and a poorly conserved Nterminal region which is considered to be a transcriptional modulation
dom ain (162-163).
In the a b sen c e of the glucocorticoid hormone, a m onom er of the
glucocorticoid receptor, two molecules of h eat shock protein (HSP90), and
several other heat shock proteins interact with each other and form an
aporeceptor complex (164). The complex is in dynamic equilibrium with two
unliganded, non-HSP90-bound receptor forms, namely an unliganded
inactive receptor that can neither bind to DNA nor en hance transcription and
an unliganded "active" receptor that can bind to DNA and enhance
transcription (165). Hormone binding leads to activation of the receptor and
dissociation of HSP90 (166), which is a substrate-specific chaperone (68,
164).

23

Proper interaction of the glucocorticoid receptor with HSP90 is
essential for efficient ligand binding and response (167-169). It w as recently
su g g ested that steroid receptors, including glucocorticoid receptors, may
require heat shock protein 70 (HSP70, or DnaK) (168) and DnaJ like proteins
(170-171), both molecular chaperones, for assem bly and m aintenance of the
aporeceptor in the a b sen ce of ligand and for proper folding of the activated
receptor after ligand binding (165).
Upon binding of the glucocorticoid to the receptor, the activated
receptor-horm one complex then translocates from the cytoplasm to the
nucleus, probably with the help of certain proteins that promote nuclear
import (172). The receptor-horm one complex binds to specific glucocorticoid
resp o n se elem ent (GRE) (173-175) on the DNA of target g e n es which allows
binding of transcription factors and RNA polym erase to initiate or inhibit
transcription. The DNA binding domain of the receptor consists of 2 cysteine
"zinc fingers" which interact with specific b a se s in the GRE (173). GR will
only fully regulate g en e transcription when it binds to the GRE in the form of
a dimer (176).
Glucocorticoid receptor is basally phosphorylated and undergoes
hyperphosphorylation after hormone-induced activation (177). In the m ouse
glucocorticoid receptor, seven phosphorylation sites have been identified by
Bodwell et al. in 1991 (178). Single mutations at all seven sites and
combinations of substitutions displayed levels of hormone-induced reporter
g en e expression that are similar to wild type receptors (179). Thus it se em s
that phosphorylation of the GR at the seven identified sites is not a major
determ inant in GR m ediated transcription activation. Therefore
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phosphorylation of various com ponents of the GR signal transduction
pathway, and not necessarily the receptor itself, may influence its
transcriptional regulation activities (180).
Phosphorylation can increase the negative charge and acidity of one
or m ore regions of a protein, influencing its interactions with other proteins or
with DNA. Thus hyper- and hypophosphorylation a t the sam e time in
different regions or at different time in the sam e region of steroid receptor
m olecules might serve a s a m echanism for differential transcription
regulation of certain g e n es (181). Furthermore, the fact that there are so
many phosphorylation sites affected by different kinases/phosphatases and
signal transduction pathways sug g ests that phosphorylation is involved in
the regulation of multiple receptor functions (181).

Insulin receptor
The insulin receptor is located on the surface of m ost mammalian
cells, including both the classic insulin target tissues (liver, muscle, and
adipose tissue) and nonclassic target tissues (blood cells, brain, etc.). The
num ber of insulin receptors ranges from less than 100 per cell to more than
200,000 per cell, the higher concentrations primarily being on adipocytes
and hepatocytes. Any insulin analogue that binds to the receptor exerts a
biological effect in proportion to its affinity for the receptor. The insulin
receptor is a transm em brane glycoprotein with a molecular weight of
approximately 350 to 440 kDa. The receptor is a heterotetram er com posed
of two a-subunits (135 kDa) and two p-subunits (95 kDa) linked by disulfide
bonds (182-183). The a subunits are located entirely outside the cell. The
two subunits are covalently linked to each other by disulfide bonds. There
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are 735 amino acids in the a subunits which contain the insulin binding sites.
The p subunits are transm em brane proteins and are com posed of a 193
amino acid extracellular domain, a 23 amino acid alpha-helical
transm em brane domain, and a 402 amino acid intracellular domain that
p o s s e s s e s an insulin-regulated tyrosine protein kinase activity (182-183).
In 1981, Kasuga et al. first reported that the insulin receptor contains
a tyrosine kinase activity (184). This finding w as later confirmed by cDNA
cloning, which revealed that the insulin receptor belongs to the family of
tyrosine kinase receptor family (185). The receptor tyrosine kinases have
b een divided into three groups (186): the epidermal growth factor (EGF)
receptor family which are monomeric with two clusters of cysteine-rich
regions in the extracellular domain and the major autophosphorylation sites
in the C term inus (187), the platelet-derived growth factor/colony-stimulating
factor 1 (PDGF/CSF-1) receptor family which have an immunoglobulin-like
distribution of cysteine residues in the external domain and a stretch of -1 0 0
amino acids which interrupts the intracellular kinase domain (188), and the
insulin receptor family which has a single cluster of cysteine residues in the
extracellular a subunits and a kinase domain in the p subunits that
resem bles the kinase domain of the prototype tyrosine kinase (189).
The tyrosine kinase activity of the insulin receptor is essential for all
known early and late cellular responses evoked by insulin (190). In the
unoccupied state, the tyrosine kinase activity intrinsic to the p subunit of the
insulin receptor is inhibited by the a subunit. This inhibition can be released
by insulin binding or removal of the a subunits using proteolytic enzym es
(191). it h as been shown that insulin binding induces a propagated
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conformational change through the transm em brane domain in the p subunit
of the receptor (192-193).
The m ost critical intracellular portion of the insulin receptor p subunit
required for normal receptor function is the co n sen su s amino acid seq u en ce
encoding an ATP binding domain marked by a distinctive glycine-rich motif
(Gly-X-Gly-X-X-Gly) followed by a lysine residue 12 amino acids
downstream . This lysine residue is absolutely required for insulin action
since substitution with any other amino acid invariably blocks
autophosphorylation and kinase activity and all biological resp o n ses (194).
There are a total of seven phosphorylation sites in the intracellular
domain of the p subunit. Activation of the insulin receptor by insulin binding
leads to the autophosphorylation of the three tyrosines in the regulatory
region in the intracellular domain of the p subunit (195). This, in turn, results
in a greatly increased kinase activity (196). Using mutation analysis, Sun et
al. w ere able to show that another autophosphorylated tyrosine residue
residing in the juxtam em brane region of the receptor is important for the
phosphorylation of endogenous receptor substrates (197). Furthermore, the
insulin receptor is under regulation by serine and threonine phosphorylation
(184).
In 1985, White et al., using antiphosphotyrosine antibodies that
recognize proteins based on the presence of the phosphotyrosine side chain
independent of the primary seq uence of the protein and 32P-labeled
hepatom a cells, identified the major intracellular substrate of the insulin
receptor, IRS-1 (originally nam ed pp185) (198). Phosphorylation of IRS-1
w as found to reach to its maximal level within seconds after the cells w ere

27

exposed to insulin. The d ose-response curve w as similar to that of receptor
autophosphorylation, suggesting that it represents the endogenous substrate
for the insulin receptor kinase. Subsequently, IRS-1 h as been found in most
cell types. The amino acid se q u en ces of IRS-1 are 98% homologous
betw een hum an and m ouse, and 90% homologous betw een hum an and rat.
IRS-1 has approximately 35 to 50 potential Ser/Thr phosphorylation
sites. It is strongly serine-phosphorylated even in the basal state. The
phosphorylation level is further increased after insulin stimulation (199). IRS1 also contains 14 potential tyrosine phosphorylation sites, six in Tyr-Met XMet motifs and three in Tyr-X-X-Met motifs (197). The fact that th e se sites
are identical in rat, m ouse, and hum ans sug g ests that they have important
functions (200). It has been shown that, following autophosphorylation of the
tyrosine residues, a num ber of cellular enzym es involved in signal
transm ission could bind reversibly to Tyr-Met X-Met or Tyr-X-X-Met sites in
som e oncogene products, and PDGF and EGF receptors (200). The proteins
that bind to th ese phosphorylation motifs have been found to contain special
recognition dom ains term ed SH2 (src homology 2) dom ains (201), which are
structural elem ents in m any proteins that bind with high affinity to
phosphotyrosine residues in activated tyrosine kinases and participate in
cellular signaling (200). SH2 dom ains have been found in som e oncogene
products (such a s src, abl, and related tyrosine kinases) (202), som e
structural proteins, several enzym es (including the phosphatidylinositol 3 kinase, the phospholipase Cy, and the GTPase-activating protein of ras)
(203), and a recently discovered class of adapter proteins represented by
th e protein Grb-2 (204).
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Phosphorylated IRS-1 h as been dem onstrated to bind strongly to
phosphatidylinositol 3'-kinase (PI-3-Kinase) (197), which phosphorylates the
lipid phosphatidylinositol. This binding has been shown to be betw een the
tyrosine-phosphorylated Tyr-Met-X-Met motifs of IRS-1 and the SH2
dom ains in the p85 subunit of the PI-3-Kinase (205). Therefore it h as been
speculated that IRS-1 might function a s a mediator in insulin signal
transm ission by binding to certain SH2 domain-containing proteins during
insulin stimulation and regulating the associated catalytic activities that
m ediate the insulin response (190). It h as also been suggested that the PI-3Kinase is involved in the insulin-induced glucose transporter translocation in
adipocytes and skeletal muscle (206)
By a m echanism not yet clear, the initial tyrosine casc ad e of insulin
action triggers a series of serine and threonine phosphorylation and
dephosphorylation reactions (190). Insulin stimulation leads to the activation
of a variety of serine protein kinases, including the MAP kinases, Raf-1
kinase, acetyl-CoA carboxylase kinase, ATP-citrate lyase kinase, casein
kinase II, and the ribosomal S6 kinases (207).
R ecent reports have linked insulin receptor signaling to the R as
activation pathway (208-209). The observations that ras mutation or
antibodies against ras abolished insulin action clearly indicated that ras is an
integral com ponent of certain insulin signaling pathw ays (210-211). It has
b een shown that all ras-related proteins bind guanine nucleotides (GTP and
GDP) and p o sse ss intrinsic G T Pase activity (212). The ras protein h a s been
su g g ested to serve a s a biological switch that is "on" when GTP is bound
and "off' when the GTP is hydrolyzed to GDP (213). The G T Pase activity of
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ras is regulated by two accessory proteins, guanine nucleotide-releasing
protein (GNRP) which catalyzes the dissociation of GDP from ras, and
GTPase-activating protein (GAP) which catalyzes hydrolysis of GTP to
control the GTP/GDP ratio. A recently cloned molecule Grb-2, which
contains one SH2 domain and two SH3 dom ains, h a s been suggested to
serve a s an adaptor in the signal pathway betw een the EGF receptor and
ras (209). The activation of R as requires autophosphorylated receptors such
a s PDGF, EGF, and IRS1. The Grb-2 binds to the IRS-1 and to a GNRP
called m Sos (mammalian son of sevenless), linking insulin action to th e ras
pathw ay (208-209, 214-218).
The key com ponent of the R as pathway is the so called mitogenactivated protein kinases (MAP kinases), or extracellular signal regulated
kinases (ERKs), which were first described by Ray and Sturgill in 1987 (219).
The R as pathway activated by tyrosine phosphorylation (220) leads to
activation of c-Raf, the serine/threonine protein kinase and protooncogene
product, which in turn activates additional serine/threonine kinases including
MAP kinase kinase/ERK kinase (MEK) (221). The activation of MAP kinase
kinase leads to the activation of serine/threonine kinases or "switch kinases"
such a s the MAP-kinases in a c asc ad e of kinase activity leading to
alterations in g e n e transcription and other cellular chan g es (153, 222). The
MAP-kinase casc ad e is triggered not only by several tyrosine kinase
receptors, but also by G protein coupled receptors (190).
The substrates for the MAP-kinases include cytoplasmic enzym es
such a s p90rek (the 90 kDa form of ribosomal protein S6 kinase), MAPKAP-
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kinase 2 (MAP kinase-activated protein kinase 2), and phospholipase A2
and a series of transcription factors such a s c-Jun, c-Myc, and c-Myb (207).
In order to elucidate the signal transduction pathway of insulin action on
g en e expression, beginning in late 1980's, researchers have been
attempting to define cis-acting seq u en ces that m ediate the effect of insulin
on gene transcription and work backward to define the m echanism s by which
the trans-acting factors that interact with th ese seq u en ces are regulated
(223-225).
With the help of mutation analysis of a num ber of insulin responsive
g e n es and functional analysis in several transfection system s, insulinresponsive elem ents (IREs) have been delineated in the 5' flanking region of
several g e n es including those for phosphoenolpyruvate carboxykinase
(PEPCK), c-fos, am ylase, pyruvate kinase, glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), glucagon, insulin-like growth factor binding
protein-1 (IGFBP-1) and malic enzym e (223-230). However, to date, none of
the proteins that bind to th ese IREs have been characterized and none of
the known transcription factors h as been found to bind to the IREs (190).
A distinctive feature of the IREs is the lack of a consensus seq u en ce and
both positive IREs and negative IREs exist. The IREs of the PEPCK gene
and IGFBP-1 gene m ediate negative regulation by insulin (225, 229, 231),
the IRE of the am ylase gene m ediates positive regulation by insulin (226),
while there are two IREs on the malic enzym e gene, one positive, the other
negative (230). One or more proteins have been shown to be able to bind to
the above mentioned IREs (225-227, 229) during gel shift assay s. None of
the proteins responsible for the different bands formed in th ese gel shift
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a ssa y s h as been characterized. N evertheless insulin h as been shown to
increase the am ount of protein that binds to the IREs for growth horm one
and GAPDH. This increase apparently resulted from a phosphorylation event
that increases the affinity of the protein for its IRE (224, 232-233). Therefore,
phosphorylation/dephosphorylation of transcription factors may serve a s a
common m echanism by which insulin regulates the transcription of a variety
of gen es.

Malic enzyme and its gene
Malic enzym e (ME; EC 1.1.1.40), the activity of which w as originally
identified in pigeon liver extracts by Ochoa et al. (234), catalyzes th e NADPdep en dent oxidative decarboxylation of m alate (235):
Malate + NADP+ -► pyruvate + C 0 2 + NADPH
The pyruvate formed in this reaction readily diffuses into mitochondria,
w here it is carboxylated to oxaloacetate by pyruvate carboxylase. The
NADPH provides reducing power required for fatty acid synthesis.
ME is a tetram er of four structurally identical subunits and is widely
distributed (236). It h as been grouped with other enzym es which are
important in lipogenesis, including the hexose-m onophosphate shunt
dehydrogenases, ATP-citrate lyase, and fatty-acid synthetase. The level of
ME strongly correlates with fatty acid synthesis and is regulated by complex
hormonal (237-239) and dietary (240-243) interactions. The ME g e n e is
transcribed into two mRNAs of 3.1 kilobase (kb) and 2.1 kb, respectively.
Although both mRNAs can be effectively translated into the functional
protein, they are differentially expressed in a tissue-specific m anner; in liver,
the 2.1 kb form is preferentially expressed while the other form is expressed
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in other mammalian tissues. However, there is no evidence up to now for a
selective transcriptional regulation, and it has been suggested that different
tissue-specific polyadenylation factors are involved (244).
Bray and York (118) reported that the levels of mRNA for ME and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) w ere increased in
liver and adipose tissue of young o b ese fa/fa rats. Hepatic ME and GAPDH
mRNA w as reduced by adrenalectom y of fa/fa rats and showed a d o se and
time d ependent increase after corticosterone replacem ent, while
glucocorticoid replacem ent had much sm aller effects on ME and GAPDH
mRNA in lean rats.
The coding nucleotide sequence of rat hepatic ME mRNA a s well a s a
882 b a se pair (bp) 5-flanking region of the ME gen e have been cloned and
seq u en ced by V. M. Nikodem's group in late 1980’s. Consistent with the
enzym e's wide tissue distribution, the structural organization of the ME
prom oter resem bles promoter regions of several eukaryotic constitutive or
"housekeeping" g e n es (245).
Deletion analyses of the ME gene promoter region show ed that
se q u en c es +1 to -41 are sufficient to initiate expression (245). Inclusion of
information up to -177 is necessary for maximal promoter activity. Further
upstream region (up to -882) contains the binding sites for many nuclear
proteins and transcription factors (Table 2, Figure 1), such a s thyroid
horm one receptor (TRE), insulin related proteins (IRE), Jun, Fos (AP-1),
Sp1, HNF3a, and glucocorticoid receptor (GRE). A TATA box (245, usually
located 20 to 30 bp upstream from cap sites, lies at -626 to -621 (Figure 1).
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Table 2. Protein binding sites on ME gene upstream region
Binding sites
IRE-1
HNF3a binding site
TATA
GRE
TRE
IRE-II
Sp1
AP-1

Positions
-693 to -687
-696 to -687
-626 to -621
-501 to -487
-281 to -266
-162 t o -169
-177 to -168
-132 t o -126

Sequence
TGT'I ITG
TATTGTTTTG
TATAAA
CAGGAAAATTGTTCT
TTGGGGTTAGGGGAGG
CCCGCCC
GCCCCGCCCC
TGACTCA

R eferences
230
246
245
247
248
230
249
249

Figure 1. The map of the upstream region of ME gene. The 925 bp upstream
region of the ME gene is shown (open bar). Sites used to generate the DNA
fragm ents to be used in the band shift a ssa y s are indicated above the open
bar with their positions. DNA fragm ents are shown a s either shaded or
hatched bars below the open bar and their sizes indicated below each
fragment. S eq u en ces that bind nuclear proteins are shown a s solid boxes in
the open bar. Restriction sites mentioned in the text are also indicated above
the open bar.
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Therefore it is of interest to investigate the binding of the hepatic
nuclear proteins from o b ese and lean Zucker rats to this region of the ME
g en e in order to gain knowledge about the m echanism of the involvement of
glucocorticoids and insulin in the developm ent of obesity.

Objectives
In order to further our understanding of the m echanism s that lead to
obesity, and to verify th e hypothesis that th e increased glucocorticoid
responsiveness in o b ese anim als is caused by altered transcription factors,
this dissertation research w as undertaken to exam ine the binding of hepatic
nuclear proteins from o b ese and lean Zucker rats to glucocorticoid regulated
g e n e s such a s ME. The initial study on the SDS PAGE and 2-D PAGE
patterns of the nuclear proteins w as also carried out. The specific objectives
are to:
1.

Subclone the 882 bp DNA fragment of the upstream region of ME g en e
into pUC19 and restrict this insert into fragm ents of the appropriate
sizes to be used in band shift assays.

2.

Perform gel retardation a ssa y s using nuclear proteins from o b e se and
lean Zucker rat liver and different fragm ents from the upstream region of
the ME gene to identify those regions of the upstream DNA that are
involved in the regulation of the rate of transcription in the rat and,
hence, are regulated differently in the lean and o b ese animals. This
would enable us to identify the site-specific DNA binding proteins in
nuclear extracts from lean and obese rats.

3.

Carry out the sam e type of experim ents using the identified DNA
fragment(s) and nuclear extracts from lean and o b ese anim als that have
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been adrenalectom ized. T hese binding studies w ere done in the
p resen ce and a b sen c e of glucocorticoid hormones, and the results w ere
com pared to those of the normal lean and obese animals. This will
m ake it possible to identify the protein that is involved in the
glucocorticoid control of ME gene.
4.

Investigate the effect of dephosphorylation and phosphorylation on the
formation of the DNA-protein complexes.

5.

Analyze the nuclear proteins present in the specific DNA-proteins
complexes.

6.

Analyze the hepatic nuclear extracts using SDS PAGE and 2-D PAGE.

MATERIALS AND METHODS

Bacterial strains and plasmids
The bacteria strains and plasmid vectors used in this study are
described in Table 3.

Media and growth conditions
All bacteria strains were routinely subcultured in LB medium (250) at
37°C, Liquid cultures w ere aerated vigorously. 1.5% (w/v) a g ar w as added
for solid media. Ampicillin when used w as added to m edia at 100 pg/ml.

Chemicals and reagents
pUC19 DNA, 10 X ligation buffer, T4 DNA ligase, DNA polym erase I
large (Klenow) fragment, VentR® (exo') DNA polym erase, and all restriction
enzym es used in this study w ere purchased from New England Biolab;
Ethylenediam inetetraacetate (EDTA), dithiothreitol (DTT),
phenylmethylsulfonyl fluoride (PMSF), pepstatin A, leupeptin, ethidium
bromide, nonidet P-40, 5-bromo-4-chloro-3-indolyl-p-D-galactoside (X-gal),
isopropylthio-a-D-galactoside (IPTG), m agnesium acetate, potasium chloride
(KCI), triton X-100, calf intestine alkaline phosphatase (CIAP), protein kinase
A (PKA), myosin, phosphorylase A, catalase, actin, carbonic anhydrase,
lysozyme and ampicillin w ere purchased from Sigma Chemical Company;
protein kinase C (PKC) w as purchased from Boehringer Mannheim;
AmpliTaq DNA Polym erase w as purchased from Perkin Elmer Cetus;
SeaK em GTG a g aro se w as purchased from FMC BioProducts; Tris-HCI,
Glycine, Magnesium chloride (MgCI2), and 10 X TBE buffer w ere purchased
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Table 3. Plasmids and host cells
Genotype

Reference

JM83

araA(lac-proAB) rpsl (strA) (<J>
80/acZAM15)

251

INVaF

F’ encfAl necA1 hsdR17 (rk",mk')
supE44 thi-1 gyrA96 re/A1 $80lacZ
AM 15 A(/acZYA-argF) U169

252

pME882-CAT

CAT

245

pCR™ll

Apr

253-254

Apr

255

Host Cells:

Plasmids:

pUC19

_
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from AMRESCO; Magic Miniprep Kit w as purchased from Prom ega; 10 X
Polym erase Chain Reaction (PCR) buffer w as purchased from Invitrogen;
Ammonium acetate w as purchased from Fisher Scientific; Sodium dodecyi
sulfate (SDS) and glycerol were purchased from United S tates Biochemicals;
2 ’-deoxyadenosine 5’-triphosphate (dATP), 2'-deoxycytidine 5-triphosphate
(dCTP), 2’-deoxyguanosine 5’-triphosphate (dGTP), 2’-deoxythymidine 5'triphosphate (dTTP), deoxyribonucleoside triphosphates (dNTPs), and
poly(dl-dC)*poly(dl-dC) were purchased from Pharm acia; [<x-32P]dATP or [a32P]dGTP w as purchased from DuPont; Sucrose w as purchased from
GIBCO BRL; Anti-glucocorticoid monoclonal antibody (BuGR2) w as
purchased from Affinity BioReagent; Anti-HNF3a antiserum w as a gift from
Dr. Ja m es Darnell.

Subcloning of a 882-bp upstream region of ME gene
The plasmid pME882-CAT (Figure 2) which contains the ME 5'
flanking region w as provided by V. M. Nikodem (245). After digestion of
pME882-CAT with restriction enzym es EcoRI and Pstl, the reaction mixture
w as loaded onto a 0.7% ag aro se gel and the gel w as run at 40 V overnight
in 1 X TBE buffer (0.09 M Tris-borate, 0.002 M EDTA, pH 8.0). After the gel
w as stained with ethidium bromide for 10 min and w ashed with w ater for 10
min, a band of 942-bp w as seen under UV light (Figure 3). This band, which
contains the 882-bp upstream region of ME gene, w as excised from the gel,
cut into small pieces (dimension approximately 2 mm x 2 mm x 5 mm), and
packed into a 0.5 ml inner elution tube which had been filled with 1 X TBE
buffer. The DNA fragm ent w as eluted using a Hoefer Scientific Instrum ents
GE 200 Eluter at 200 V, for 3 hours. The eluted DNA w as then added to a

EcoRI.l
5000

1000
4000

pM E 882-C A T

CAT

5100 bps

3000

2000

Figure 2. The m ap of pME882-CAT. The CAT g en e is indicated by a solid
arrow. The 925 bp upstream region of ME g en e carried by this piasmid is
shown a s a shaded bar. Restriction sites are indicated and num bered
according to their distance to the EcoRI site.
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1

2

O 942 bp

Figure 3. Generation of the 942 bp DNA fragment. Digestion of pME882CAT with EcoRI and Pstl gave rise to a 942 bp DNA fragm ent that contains
the 925 bp upstream region of the ME gene. Lane 1 show s the 1 kb DNA
ladder used a s a DNA size marker. Lane 2 shows the digestion reaction
resolved on a 0.7% ag aro se gel. The position of the 942 bp DNA fragm ent in
lane 2 is indicated by an arrow on the right.
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centricon (Amicon) with a cut-off of 10,000 MW, centrifuged at 3500 rpm in
an International Equipment Company HN-SH centrifuge at 4°C for 3 hours.
100 ng of the 942-bp DNA and 100 ng of pUC19 DNA, which had been
digested with EcoRI and Pstl, w ere added into a ligation reaction which
contained 1 X ligation buffer and 400 units of T4 DNA ligase in a total
volume of 20 pi. The ligation reaction w as carried out at 16°C overnight. The
recom binant DNA w as then transformed into com petent JM83 cells following
the procedures described by Maniatis et al. (256) The transfected cells which
contained recom binant plasmid w ere identified a s white colonies by plating
dilutions of the transformation on L-agar, into which 10Opg/ml ampicillin had
been added, in the presence of the chromogenic substrate X-gal and the
gratuitous inducer of p-galactosidase IPTG. The recombinant plasmid w as
purified using Magic Miniprep Kit. After digestion of the plasmid with
restriction enzym es Aflll-Notl and Notl-Pstl, the insert w as confirmed by
loading the restriction digestion mixture onto a 5% polyacrylamide gel
electrophoresis (PAGE) and run at 25 V, overnight with 1 X TBE a s running
buffer (Figure 4). The recombinant plasmid w as nam ed pME925 (Figure 5).
Two other DNA fragments, representing -881 to -696 and -712 to -491
of the ME gene, w ere generated by polym erase chain reaction (PCR)
amplification using gel purified, EcoRI digested pME925 a s tem plate. The
primers used in the PCR reactions were designed using a primer designer
program, Primer 2 (Scientific & Educational Software) and w ere synthesized
by the G eneLab at the School of Veterinary Medicine Louisiana State
University. The nam es and seq u en ces of the primers are shown in Table 4.
The PCR reactions w ere performed in a Perkin Elmer C etus DNA thermal
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Figure 4. Generation of the 134 bp and 385 bp DNA fragm ents. Digestions of
the plasmid pME925 with Notl-BamHI and Aflll-Notl gave rise to a 134 bp
and 385 bp DNA fragm ents, respectively. Lane 1 show s th e 100 bp DNA
ladder used a s a DNA size marker. Lane 2 (Notl/BamHI) and 3 (Aflll/Notl)
contain the digestion reactions resolved on a 5% PAGE. Positions of the 134
bp and 385 bp DNA fragm ents are indicated by the arrows on the right.
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Figure 5. Cloning of a 945 bp EcoRI-Pstl DNA fragment into pUC19 vector.
T he plasmid pME882-CAT w as digested using EcoRI and Pstl and a 942 bp
DNA fragm ent containing ME upstream region w as isolated. The DNA
fragm ent w as then ligated into EcoRI-Pstl digested pUC19 vector.

Table 4. Primers used in PCR reactions

N am es
MECLN1A
MECLN1B
MECLN2A
MECLN2B
ME49A
ME49B

S eq u en ces
CGCATAGCCCAGAAG
ACAGCCAAGCAGCCT
GAAGGCTGCTTGGCTGTATTG
CAAI rTTCCTGAGCGT i CTGG
CCAGAACGCTCAGGAA
CAGTGGCCAGTCCTAT
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cycler. Each PCR reaction consisted of 90 ng of the tem plate DNA, 1 X PCR
buffer, 0.5 mM dATP, 0.5 mM dCTP, 0.5 mM dGTP, 0.5 mM dTTP, 1 pM of
each of the two primers, and 1 unit of the therm ostable Taq DNA polym erase
in a total volume of 50 pi. The primers MECLN1A and MECLN1B w ere used
in the PCR reaction to generate the 186 bp DNA fragment and the primers
MECLN2A and MECLN2B w ere used in the PCR reaction to g enerate the
222 bp DNA fragment. B ecause the non-template dependent activity of the
therm ostable polym erase used in PCR adds single deoxyadenosines to the
3’-end of all duplex molecules, the resulting 186 bp and 222 bp DNA
fragm ents w ere ligated into the specifically designed plasmid vector
Invitrogen pCR™ll, which provides single 3' T-overhangs at the insertion
site. The therm ocycles used are described in Table 5. The recombinant
plasmid generated using primers MECLN1A and MECLN1B w as designated
pME186 and the one generated using primers MECLN2A and MECLN2B,
pME222 (Figure 6).

End labeling target DNA
Labeled DNA fragm ents used in the band shift a ssa y s w ere prepared
by digestion of the plasmids pME925, pME186 or pME222 with different
restriction enzym es and filling in with either [a-32P]dATP or [a-32P]dGTP
depending on the se q u en c es of the 3-recessive ends of the fragm ents.
The plasmid pME925 w as digested with the restriction enzym es AflllNotl or Notl-BamHi, the plasmid pME186 w as digested with EcoRI, and the
plasmid pME222 w as digested with EcoRI and EcoRI-PflMI.
The labeling reactions were carried out with 1 pg digested plasmid
DNA, 0.5 mM dNTPs a s needed, 0.825 pM (50 pCi) [a-32P]dATP or
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Table 5. Thermocycles used for PCR
N am es of
Primers
the products used
MECLN1A
ME186
MECLN1B

Thermocycles
94°C, 1 min
47°C, 1 min
72°C, 1 min

Number of
Cycles
25

ME222

MECLN2A
MECLN2B

94°C, 1 min
50°C, 1 min
72°C, 1 min

25

ME49

ME49A
ME49B

94°C, 1 min
41°C, 1 min
72°C, 3 se c

25

Delay
72°C
10 min

72°C
10 min

wzzzzmm

_► «_ ME222

L igation
.EcoRI, 1
4000

1000

MOO

2000

L igation
.BcoKM

1000

Figure 6. Construction of the plasmids pME186 and pME222. A 186 bp and
a 222 bp DNA fragm ents were obtained using PCR. The 942 bp DNA
fragm ent w as used a s the template. The DNA fragm ents w ere then ligated
into the pCRII vector which provides single 3’ T-overhangs at the insertion
site. The solid bar represents the 925 bp upstream region of the ME gene.
The restriction sites were indicated above the solid bar. The positions of the
two DNA fragm ents relative to the 925 bp upstream region of ME g en e are
shown with the hatched bars below the solid bar.
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[a-32P]dGTP and 5 units Klenow fragment in a total volume of 20 pi. After
incubation at 37°C for 15 min, the labeling mixtures were loaded onto a 5%
polyacrylamide gel and electrophoresed at 200V, room tem perature for 40 to
60 min. And the bands w ere visualized by staining with ethidium bromide a s
described above. The bands w ere then cut out of the gel with a lancet and
transfered into a microcentrifuge tube containing 200 pi elution buffer which
is com posed of 0.5 M ammonium acetate, 1 mM EDTA, 10 mM m agnesium
acetate, and 0.1% SDS, and shaken at 225 rpm in a 37°C incubator
overnight. The elution buffer containing the DNA fragm ents w as then
transfered to another microcentrifuge tube and the gel slices w ere eluted
with a second 100pl elution buffer and the eluate combined. After adding 30
pi sodium acetate (pH 5.4), 750 pi of ethanol w as added and the mixture
cooled to -75°C for 15 min. The tube w as then centrifuged at 14,000 rpm, 4°
C for 10 min in an eppendorf 5402 centrifuge. The pellet w as then w ashed
with 70% ethanol. After vortexing briefly, the tube w as centrifuged at 14000
rpm, 4°C for 10 min. The pellet w as then dried in a vacuum cham ber for 15
min, desolved in 100 pi deionized and distilled w ater and stored at 4°C. The
specific activity of the labeled probes w ere m easured using a Beckman
LS6000TA liquid scintillation system and were betw een 12,000 to 15,000
cpm/pl.

PCR amplification and labeling of the 49-bp probe
A 49 bp DNA fragm ent containing a GRE site w as generated and
labeled with [a-32P]dATP using PCR. The primers designed for the PCR
reaction w ere synthesized by the GeneLab at the School of Veterinary
Medicine Louisiana S tate University and are shown in Table 4. The PCR
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reaction w as carried out in a 50 pi solution containing 90 ng of EcoRI
digested pME925 DNA a s template, 1 X PCR buffer, 0.5 mM dTTP, 0.5 mM
dGTP, 0.5 mM dCTP, 1.65 pM (100 pCi) [a-32P]dATP, 1 pM of each of the
primers (ME49A and ME49B), and 1 unit VentR® (exo') DNA polym erase
which d o e s not degrade the PCR product when there are unequal dNTP
concentrations and h a s a fidelity level twice that of Taq DNA polym erase.
The therm ocycles are described in Table 5. The PCR reaction w as then
loaded onto a 5% non-denaturing polyacrylamide gel and purified a s
described above.

Animals
Zucker lean and o b e se rats from two sources have been used in the
described experiments. In the gel retardation experim ents o b ese (fa/fa) and
lean (Fa/fa or Fa/Fa) rats w ere bred from heterozygote parents. For SDS
PAGE and 2-D PAGE analysis, we used rats from a Zucker X Brown Norway
cross colony to identify known homozygous lean (Fa/Fa) and o b e se (fa/fa)
rats. This cross provides a restriction fragm ent length polymorphism close to
the fa g e n e that allows determination of the num ber of fa g e n e s carried with
an error of less than 1% (257).
All rats w ere bred in the AALAC-accredited animal facility of the
Pennington Biomedical R esearch Center. They w ere housed singly, after
weaning at 21 days, in hanging wire cag e s with an autom ated w ater system
in room s maintained at 22-240C with a 12 hour (08.00 to 20.00 hour) lightdark cycle. Food (laboratory rodent #5001, PMI F eeds Inc.) w as available ad
libitum.
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Bilateral adrenalectom ies or sham -operations were performed under
m etofane anesthesia a s described previously (116). During the immediate
24-hour postoperative period all rats were maintained at 24-26°C, before
being returned to normal housing tem perature. Adrenalectomized rats were
m aintained on a 0.9% (w/v) saline drinking solution. Som e adrenalectom ized
rats w ere treated with dexam ethasone (0.5 mg/kg body weight, daily) for two
days before sacrifice, which w as seven days after the operation. The
dexam ethasone w as injected intraperitoneally in an Tween-20/ethanol/0.9%
(w/v) NaCI (1:25:975, by volume) vehicle. All control animals received a
similar volume of vehicle. Immediately after decapitation of the rats, trunk
blood w as collected for the preparation of serum . The su c ce ss of the
adrenalectom y procedure w as confirmed by demonstration of undetectable
serum corticosterone levels in a radioim m unoassay procedure a s previously
described (116).

Preparation of hepatic nuclear extracts
Nuclear proteins w ere prepared from extracts of purified nuclei of lean
and o b ese Zucker rats by the method of Bernal et al. (258). All manipulations
w ere performed in the cold, and all solutions, tubes, and centrifuges w ere
chilled to 0°C. When included, DTT, PMSF, Pepstatin A, and Leupeptin w ere
added to the buffers just prior to use. Rats were decapitated at the ag e of 46 w eeks. 7.5 g liver w as minced and homogenized in SMDP solution
containing 0.32 M sucrose, 1 mM MgCI2l 1 mM DTT, 1 mM PMSF, 1 pM
pepstatin A, and 1 pM leupeptin, and centrifuged at 1090 x g in a Beckman
J2-21M centrifuge for 10 min. The pellet w as w ashed with SMDP solution,
resedim ented and resuspended in 2.4 M sucrose containing 1 mM PMSF
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and 1 mM DTT. It w as centrifuged in a Beckman fixed angle Ti 50.2 rotor at
130,000 xg for 45 min. The pellet w as resuspended in 9 ml of SMTDP
solution (0.32 M sucrose, 1 mM MgCI2l 1 mM DTT, 1 mM PMSF) to which
250 pi of 10% triton X-100 w as added. After incubation at 4°C for 5 min, the
pellet w as sedim ented at 1090 xg in a Beckman J2-21M centrifuge for 10
min and w ashed with 10 ml of SMTDP solution. The pellet w as used a s
purified nuclear fraction. The purified nuclei w ere lysed in 10 mM Tris-HCI
buffer pH 8.0 containing 0.4 M KCI, 1 mM MgCI2, 1 mM DTT, 1 mM PMSF,
incubated for 1 hour with occasional mixing, centrifuged in Beckman Ti 50.2
rotor at 150,000 x g for 1 hour. The supernatant w as frozen with liquid
nitrogen in small aliquots and w as stored at -80°C. It w as used a s nuclear
protein extract in the gel retardation studies, SDS PAGE, and 2-D PAGE.
Protein content w as assayed using the Bio-Rad dye binding method of
Bradford (259). O nce thawed, the extracts w ere not refrozen.

Gel retardation studies
Binding reactions were carried out basically a s described by Petty et
al. (248). 1 or 2 pg of Zucker rat liver nuclear extract w as added to 20 pi of
binding buffer containing 125 mM Tris-HCI (pH 8.0), 25 mM MgCI2 (to adjust
ionic strength), 2.5 mM EDTA (as a chelation agent), 50% glycerol (to
stabilize the binding), 0.1% Nonidet P-40 (to minimize aggregation), 2.5 mM
dithiothreitol (as a reducing agent), 250 mM NaCI (to adjust ionic strength),
and 0.5 mg/ml poly(dl-dC)*poly(dl-dC) (as a nonspecific competitor DNA). 2
pi of labeled probe w as then added and incubation w as continued for 20 min
at room tem perature. After addition of 2 pi of 10X loading buffer (0.1%
bromphenol blue and 50% glycerol) reaction mixtures w ere loaded onto a
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1.5 mm x 14 cm x 16 cm polyacrylamide gel (4 or 5%,
acrylamide:bisacrylamide, 37.5:1) that had been pre-electrophoresed at 100
V for a t least 30 m inutes in a buffer of 50 mM Tris, 0.38 M glycine, 2 mM
EDTA, pH 8.3. Electrophoresis w as carried out at 200 V, 4°C until the
bromphenol blue dye front reached the bottom of the gel. Gels w ere dried
and exposed to a Molecular Dynamics Phosphoim ager screen or an X-ray
film.
Gel shift interference experim ents were carried out under the sa m e
conditions a s described above for the gel retardation a ssa y except that after
adding nuclear extract in the binding buffer, the incubations w ere carried out
in th e p resence of specified am ount of phosphatase, protein kinases, or
antibodies. CIAP, PKA, or PKC w as incubated with the nuclear proteins at
30°C for 30 min. BuGR2 or HNF3a antiserum w as incubated with the
nuclear proteins at room tem perature for 20 min.

SDS PAGE of proteins in DNA-protein complexes from band shift
assays
In order to analyze the proteins present in the bands of interest in the
band shift a ssa y s, 15 fold scale-up band shift a ssa y s w ere performed with
the 222 bp DNA fragm ent a s labeled probe. Band shift a ssa y s w ere carried
out a s described above except that two control reactions w ere run without
any target DNA added. After exposure to the X-ray films, the original gels
w ere aligned with the X-ray films and the bands of interest w ere excised from
the gel. The gels in which control reactions w ere loaded w ere also aligned
with the X-ray films obtained from band shift a ssa y s performed with labeled
probes and the gel slices at the sam e position were excised. The excised gel
slices w ere chopped into small pieces and the proteins in the gels w ere
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eluted using a Hoefer GE 200 Eluter a t 4°C, 200 V for 3 hours. The eluted
proteins w ere then concentrated using an Amicon centricon (10,000 M.W.
cut-off) a s described above. After denaturation at 95°C for 5 min in the
SD S/sam ple buffer (5% SDS, 5% beta-m ercaptoethanot, 10% glycerol and
60 mM Tris, pH 6.8), the concentrated proteins were loaded onto a Millipore
pre-cast 4-20% SDS polyacrylamide gel (8 cm x 7 cm x 1 mm) and run at
200 V for 1 hour in a Hoefer SE 250 Mighty Small II Vertical Slab Unit.
BioRad SDS-PAGE Molecular Weight Standards w as also loaded on the gel
to show the sizes of the proteins. The gel w as then stained with the BioRad
silver stain kit following the instruction provided by the manufacturer. Black
and white pictures of the stained gel w ere then taken using a Nikon 700
cam era.

Analysis of the hepatic nuclear proteins using polyacrylamide gel
electrophoresis
SPS PAGE
Hepatic nuclear proteins from obese and lean Zucker rats were
subjected to SDS PAGE. 5 pg of each of the nuclear extracts w as heated at
95°C for 5 min in 50 pi of SD S/sam ple buffer and loaded onto an 8% SDS
PAGE (1.5 mm x 16 cm x 12 c m ). The gel w as run at 10 mA until the
bromphenol blue dye front reached the bottom of the gel. The gel w as then
silver stained and its pictures taken a s described above.
2-D PAGE
Two-dimensional electrophoresis w as performed according to the
method of O'Farrell (260) by Kendrick Labs, Inc. (Madison, Wl) a s follows:
Isoelectric focusing w as carried out in glass tubes of inner diam eter
2.0 mm, using 2.0 Resolytes pH 4-8 ampholines (BDH from Hoefer Scientific
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Instruments) for 9600 volt-hours. One pg of an IEF internal standard,
tropomyosin protein, with lower spot of M.W. 33,000 and pi 5.2 w as added to
the sam ples. This standard is indicated by an arrow on the stained 2-D gel.
After equilibration for 10 min in a buffer containing 10% glycerol, 50
mM dithiothreitol, 2.3% SDS and 0.0625 M Tris, pH 6.8, the tube gels w ere
sealed to the top of stacking gels which are on top of 10% acrylamide slab
gels (0.75 mm thick) and SDS slab gel electrophoresis carried out for about
4 hours at 12.5 mA/gel. The following proteins w ere added a s M.W.
standards to the a g aro se which sealed the tube gel to the slab gel: myosin
(220,000), phosphorylase A (94,000), catalase (60,000), actin (43,000),
carbonic anhydrase (29,000) and lysozyme (14,000). T hese standards
ap p ear a s horizontal lines on the C oom assie Brilliant Blue R-250 stained
10% acrylamide slab gels. The C oom assie blue stained gels w ere dried
betw een sh e ets of cellophane with the acid ed g e to the left.
For protein purification, the slab gels w ere transferred to transfer
buffer (12.5 mM Tris, pH 8.8, 86 mM glycine, 10% methanol) transblotted
onto PVDF paper overnight at 4°C, 200 mA and approximately 100 V/2 gels.
The m em branes w ere stained in 50% methanol and 0.1% Coom assie
Brilliant Blue for 5 min, destained in 50% m ethanol for 2 min and rinsed 10
minutes six tim es in ultrapure water. The m em branes w ere then dried
betw een sh e e ts of filter paper. The protein spots of interest w ere cut out of
the PVDF paper with a razor blade and sen t to Baylor College of Medicine
for g a s p h ase sequencing analysis.

RESULTS

Subcloning of ME 5' flanking region
T he 942 bp EcoRI-Pstl fragment containing th e 5’ flanking region w as
subcloned from pME882-CAT into pUC19 (Figure 5). The entire seq u en ce of
the recom binant plasmid w as determined using the W isconsin S equence
Analysis Package™ (Genetics Computer Group, Inc.). The insert w as
confirmed by restriction analysis (Figure 3). The se q u en c es of the PCR
subcloned inserts in the recombinant plasmids pME222 and pME186 w ere
also determ ined. The digestion of pME925 with different restriction enzym es
gave rise to a 385 bp fragm ent (Aflll-Notl) and a 134 bp fragment (NotlBamHI) (Figure 4). The digestion of pME222 with EcoRI yielded a 222 bp
fragm ent (Figure 7), while a double digestion of th e sam e plasmid with EcoRI
and PfIMI generated two other fragm ents with the length of 70 bp and 152 bp
respectively (Figure 8). The 186 bp fragment w as obtained by cutting the
pME186 with EcoRI (Figure 7).
The TRE, IRE-II, and AP-1 sites fall into the 385 bp fragment. The
GRE, IRE-I, and HNF3 sites fall into the 222 bp fragment, with the GRE in
the 152 bp fragment, while the IRE-I and HNF3 sites are contained in the 70
bp fragm ent (Figure 1, Table 2).

Binding of the nuclear extracts to the DNA fragments
The first goal of this study w as to verify the hypothesis that the higher
hepatic ME mRNA level in o b ese Zucker rats is caused by enhanced
transcription activation of the ME gene. As would be described below, this
hypothesis w as proven true. The next step w as to identify the location of the
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Figure 7. Generation of the 222 bp and 186 bp DNA fragm ents to be used in
the band shift assays. Digestions of the plasmids pME222 and pME186 with
EcoRI gave rise to a 222 bp and 186 bp DNA fragments, respectively. Lane
1 show s th e 100 bp DNA ladder used a s a DNA size marker. Lane 2
(pME186) and 3 (pME222) contain the digestion reactions resolved on a 5%
PAGE. Positions of the 222 bp and 186 bp DNA fragm ents are indicated by
the arrows on the right.

Figure 8. Generation of the 152 bp and 70 bp DNA fragm ents to be used in
the band shift assay s. Digestions of the plasmids pME222 with EcoRI-PflMI
gave rise to a 152 bp and 70 bp DNA fragments, respectively. Lane 1 show s
the 100 bp DNA ladder used a s a DNA size marker. Lane 2 contains the
digestion reaction resolved on a 5% PAGE. Positions of the 152 bp and 70
bp DNA fragm ents are indicated by the arrows on the right.
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DNA se q u en c es that are bound differentially by the nuclear extracts from
o b e se and lean Zucker rats. Thus the band shift experim ents w ere initially
performed with five DNA fragments, which together cover the entire 882 bp
upstream region of the ME gene. The im ages obtained by scanning the
phosphoim ager screen are shown in Figures 9-10,12-14.

Band shift assay with the 134 bp DNA
The 134 bp DNA fragment used in the band shift a ssa y shown in
Figure 9 w as generated by digestion of the plasmid pME925 with Notl and
BamHI and is located at -102 to + 33 of the ME gen e (Figure 1). Up to seven
bands w ere seen when this 134 bp DNA fragment, which w as labeled with
[a-32P]dATP, w as incubated with hepatic nuclear extract from lean and
o b e se rats (Lanes 2 and 3 of Figure 9). The single band in lane 1 showed
the position of the free labeled 134 bp DNA.
The specificity of the binding w as dem onstrated by competition
experim ents, in which the binding reaction w as performed in the p resence of
e x ce ss unlabeled competitor. In lanes 4 and 5, 30-fold of unlabeled target
DNA (the 134 bp fragment) w as included in the binding reaction a s a
competitor. As can be seen , th e bands that represent the formation of the
DNA-protein com plexes disappeared with the addition of the unlabeled
competitor. Thirty fold of sonicated E. coli DNA w as included in the binding
reactions shown in lanes 6 and 7, and the formation of the DNA-protein
com plexes w ere not com peted by this unrelated DNA.
There w as no significant difference between the levels at which this
134 bp DNA fragm ent w as bound by the hepatic nuclear proteins from o b ese
and lean rats (Appendix A). The overall patterns by which the nuclear
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Figure 9. Band shift a ssa y with the 134 bp fragment. Hepatic nuclear
extracts prepared from o b ese and lean Zucker rats w ere incubated with 32Plabeled DNA fragm ents containing the -102 bp to +33 bp region of ME gene,
together with or without unlabeled target DNA or E. coli DNA. DNA-protein
com plexes w ere size fractionated in nondenaturing polyacrylamide gels and
w ere detected by autoradiography. The arrows on the right indicate th e
positions of the shifted complexes. +: present, -: absent, O: ob ese, L: lean.
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proteins bind to the 134 bp DNA fragment w ere sam e in o b ese and lean
animals.

Baitd_shift_assay with the 385 bp DNA
T he 385 bp DNA fragment located betw een -488 and -103, the region
which contains a TRE, Sp1, AP-1 and the IRE-il. It w as prepared by
digestion of pME925 with Not) and Aflll (Figure 4) and labeled with [a32P]dGTP using Klenow fragment. The binding of the nuclear proteins from
o b e se and lean Zucker rat liver to the labeled 385 bp DNA fragm ent resulted
in four major bands in the band shift a ssay shown in Lanes 2 (lean nuclear
proteins) and 3 (obese nuclear proteins) in Figure 10. The position of the
unbound labeled target DNA w as shown in lane 1 which serv es a s a control.
It w as obvious in all the four bands shown in lanes 2-3 that more
hepatic nuclear proteins from o b ese Zucker rats bound to the 385 bp DNA
when com pared to lean Zucker rats (Appendix B). The formation of all the
four DNA-protein com plexes are specific b ecau se the addition of 30-fold
ex ce ss unlabeled target DNA com peted with and replaced the labeled DNA
(lanes 4-5) in the bands that w ere shown in lanes 2-3 and the inclusion of
unrelated DNA did not change the formation of any of the bands (lanes 6-7).
The difference betw een the binding of nuclear proteins from o b e se
Zucker rats and that from lean Zucker rats w as in the am ount of the DNA
that w as bound.

Band shift assay with the 222 bp DNA
The region from -712 to -491 of ME gene is covered by a 222 bp DNA
fragm ent which contains an HNF3 binding site, an IRE-I, a TATA box, and a
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Figure 10. Band shift a ssa y with the 385 bp fragment. Hepatic nuclear
extracts prepared from o b e se and lean Zucker rats w ere incubated with 32Plabeled DNA fragm ents containing the -488 bp to -103 bp region of ME gene,
together with or without unlabeled target DNA or E. coli DNA. DNA-protein
com plexes w ere size fractionated in nondenaturing polyacrylamide gels and
w ere detected by autoradiography. The arrows on the right indicate the
positions of the shifted complexes. +: present, -: absent, O: obese, L: lean.
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potential GRE site (Figure 1). It w as obtained by digestion of pME222 with
EcoRI and radioisotope-labeled using Klenow fragment.
At least four bands w ere se en when this fragment, labeled with [a32P]dATP, w as incubated with the nuclear proteins from both o b ese and lean
Zucker rat liver (lanes 2-3 in Figure 11). Lane 1 in Figure 11 has only the
labeled 222 bp fragment and w as used a s a control reaction. Band shift
a ssa y s performed in the presence of 30-fold of unlabeled 222 bp fragm ent
DNA (lane 4) showed a disruption of the binding by the nuclear proteins to
the labeled target DNA. Addition of 30-fold of sonicated E. coli DNA to the
band shift a ssa y failed to affect the binding of the nuclear proteins to the
labeled target DNA.
Interestingly, the pattern of binding of hepatic nuclear proteins to this
222 bp DNA fragm ents w ere clearly different betw een o b ese and lean rats
(lanes 2-3 in Figure 11). There w as more Complex 1 formed by o b ese
nuclear extract than by lean nuclear extract. On the other hand, there w as
more of complex 2, 3, and 4 formed by lean nuclear extract than by o b e se
nuclear extract (Appendix C). Therefore, this region w as selected for more
thorough examination a s will be described below.

Band shift assay with the 186 bp DNA
The 186 bp DNA fragment from -881 to -696 of ME gen e w as
obtained by digestion of pME186 with EcoRI and labeled with [a-32P]dATP
using Klenow fragment. It does not contain any known protein binding site.
However, there were still two DNA-protein complexes formed when this 186
bp fragm ent w as used in band shift a ssa y (Figure 12). The formation of
th e se DNA-protein com plexes w as specific b ecau se the addition of 30-fold
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Figure 11. Band shift a ssa y with the 222 bp fragment. Hepatic nuclear
extracts prepared from o b ese and lean Zucker rats w ere incubated with 32Plabeled DNA fragm ents containing the -712 bp to -491 bp region of ME gene,
together with or without unlabeled target DNA or E. coli DNA. DNA-protein
com plexes w ere size fractionated in nondenaturing polyacrylamide gels and
w ere detected by autoradiography. The arrows on the right indicate the
positions of the shifted complexes. +: present, absent, O: obese, L: lean.
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Figure 12. Band shift a ssa y with the 186 bp fragment. Hepatic nuclear
extracts prepared from obese and lean Zucker rats were incubated with 32Plabeled DNA fragm ents containing the -881 bp to -696 bp region of ME gene,
together with or without unlabeled target DNA or E. coli DNA. DNA-protein
com plexes w ere size fractionated in nondenaturing polyacrylamide gels and
w ere detected by autoradiography. The arrows on the right indicate the
positions of the shifted complexes. +: present, absent, O: obese, L: lean.
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ex ce ss of unlabeled 186 bp target DNA negated the formation of the
com plexes by the nuclear proteins from o b ese and lean Zucker rat liver, and
labeled target DNA and the inclusion of 30-fold ex ce ss of unrelated DNA did
not affect the formation of th ese DNA-protein complexes.
There w as a difference betw een the levels at which this 186 bp DNA
fragm ent w as bound by the hepatic nuclear proteins from o b ese and lean
rats. It w as bound at a much higher level by nuclear proteins from o b ese rat
liver than by the ones from lean rat (Appendix D). However the pattern of
binding of hepatic nuclear proteins w as similar in extracts from o b ese and
lean rats.

Band shift assay with the 49 bp DNA
To investigate the binding of the nuclear proteins from o b e se and lean
Zucker rat liver to the GRE site, a 49 bp DNA fragm ent w as generated and
labeled with [a-32P]dATP using PCR (Figure 13) a s described in Materials
and Methods. It covers the region -511 to -463 of the ME gen e and contains
only a GRE site (Figure 1, Table 4).
A single DNA-protein complex w as se en when this 49 bp DNA
fragm ent w as used a s labeled probe in the band shift a ssa y with nuclear
proteins from o b ese and lean Zucker rat liver (lanes 2 and 5 in Figure 14).
T here w as a higher concentration of proteins that bind to this 49 bp DNA
fragm ent in o b e se Zucker rats when com pared to lean (Appendix E). The
formation of th ese DNA-protein com plexes w as specific b ecau se the addition
of 30-fold ex ce ss unlabeled target DNA com peted with and replaced the
labeled DNA (lanes 3 and 6) in the bands that w ere shown in lanes 2 and 5
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Figure 13. Generation of the 49 bp DNA fragment to be used in the band
shift a ssay s. PCR amplication using the 925 bp DNA fragment a s tem plate
and the oligonucleotides ME49A and ME49B a s primers gave gave rise to a
49 bp and 70 bp DNA fragments, respectively. Lane 1 show s the 100 bp
DNA ladder used a s a DNA size marker. Lane 2 contains the digestion
reactions resolved on a 5% PAGE. Positions of the 49 bp DNA fragm ents
are indicated by the arrow on the right.
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Figure 14. Band shift a ssa y with the 49 bp fragment. Hepatic nuclear
extracts prepared from o b ese and lean Zucker rats w ere incubated with 32Plabeled DNA fragm ents containing the -511 bp to -463 bp region of ME gene,
together with or without unlabeled target DNA or E. coli DNA. DNA-protein
com plexes were size fractionated in nondenaturing polyacrylamide gels and
w ere detected by autoradiography. The arrow indicates the position of the
shifted complexe. +: present,
absent, O: obese, L: lean
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and the inclusion of unrelated DNA did not change the formation of any of
the bands (lanes 4 and 7).

Adrenalectomy abolishes the binding of nuclear extract to ME222
B ecause adrenalectom y has been reported to be able to prevent or
su p p ress the developm ent of almost all the experimental obesity models,
including Zucker rats (46), and the mRNA level of hepatic ME in o b ese
Zucker rats h as also been shown to be reduced to the level of that in lean
Zucker rats (130), it w as of interest for us to investigate the effect of
adrenalectom y on band shift patterns with the upstream region of the ME
gene. Since the pattern of binding of the hepatic nuclear proteins from o b ese
and lean Zucker rats to the 222 bp DNA fragment, which contains a GRE
site, an IRE-I site, and an HNF3 binding site, w as shown to be different. W e
c h o se this 222 bp DNA fragment to further study the effect of the statu s of
adrenal glucocorticoids on the binding of the hepatic nuclear proteins.
W hen nuciear extracts from sham anim als w ere used in the band shift
assay , there w as m ore Complex 1 formed by hepatic nuclear proteins from
o b e se anim als than by that from lean anim als (lanes 2-3 in Figure 15,
Appendix F), and there w ere slightly less Com plexes 2-4 formed by hepatic
nuclear proteins from o b e se Zucker rats than by those from lean Zucker rats.
This w as consistent with the results obtained from the band shift a ssa y s
performed with nuclear extracts from o b ese and lean Zucker rats that did not
receive any surgery. This indicated that the sham operation did not affect the
binding of the nuclear proteins to the 222 bp fragment. The single band in
lane 1 in Figure 15 indicated the position of the labeled 222 bp target DNA
w hen it w as not bound by any proteins.
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Figure 15. The effect of adrenalectom y on band shift pattern with the 222 bp
fragment. Hepatic nuclear extracts prepared from o b ese and lean Zucker
rats that had been adrenalectom ized, adrenalectom ized and dexam ethasone
treated, or sham operated, were incubated with 32P-labeled DNA fragm ents
containing the -712 bp to -491 bp region of ME gene. DNA-protein
com plexes were size fractionated in nondenaturing polyacrylamide gels and
w ere detected by autoradiography. The arrows on the right indicate the
positions of the shifted complexes. +: present, absent, O: obese, L: lean,
S: sham , A: adrenalectom y, D: dexam ethasone.
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The formation of Complex 1 by adrenalectom ized o b e se rat nuclear
extracts w as reduced to approximately the level lower than that of sham lean
rat nuclear extracts (lane 4) and the Complex 1 formed by adrenalectom ized
lean nuclear extracts w as reduced even further (lane 5). After
d ex am ethasone treatm ent, the o b ese adrenalectom ized rat nuclear extracts
evidenced a larger am ount of proteins that bind to the 222 bp DNA fragm ent
than sham o b e se rat nuclear extracts (lane 6 in Figure 15, Appendix F) and
th e lean adrenalectom ized rat nuclear extracts bound in a higher level to the
222 bp DNA fragm ent than sham lean rat nuclear extracts although still
slightly lower than sham o b ese nuclear extracts.
T he levels of com plexes 2-4 formed by th e hepatic nuclear proteins
from adrenalectom ized and dexam ethasone replaced o b e se and lean
Zucker rats w ere affected by the glucocorticoid status manipulation in an
opposite way to the levels of Complex 1.

Dephosphorylation of nuclear proteins abolished the binding
Protein phosphorylation is one of the most frequent forms of
posttranslational modification in eukaryotic cells and is linked to the control of
a variety of cellular functions (158, 222). Glucocorticoid receptor, a steroid
horm one receptor, is a phosphoprotein and undergoes hyperphosphorylation
after horm one-induced activation (177). Insulin receptor, a representative of
peptide horm one receptors, is not only a phosphoprotein, but also on e of the
receptor tyrosine kinases (184-189). B ased on our above observation that
there w ere differences betw een the patterns with which the hepatic nuclear
proteins from o b ese and lean Zucker rats bind to the 222 bp DNA fragment,
which contains both an IRE-I and a GRE, it w as rational to further investigate
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the influence of the phosphorylation status of the hepatic nuclear proteins on
their binding to the 222 bp DNA fragment.
First, w e used CIAP to dephosphorylate the hepatic nuclear proteins
from o b ese and lean Zucker rats. 0.2-4 units of CIAP w as incubated with the
nuclear proteins in the band shift reactions for 30 min before labeled probe
w as added. As the am ount of the CIAP increased, the formation of the
specific DNA-protein Com plexes 1-3 decreased, regardless of w hether the
hepatic nuclear proteins used in the band shift a ssa y s were from o b e se
Zucker rats (lanes 4, 6, 8 ,1 0 ,1 2 in Figure 16) or lean Zucker rats (lanes 5, 7,
9, 11, 13 in Figure 16, Appendix G). This suggested that one or m ore of the
proteins that formed Com plexes 1-3 need to be phosphorylated in order to
bind to the DNA or interact with each other.
In contrast, the intensity of Complex 4 w as increased when the
am ount of the CIAP increased, this w as the c a se with com plexes formed by
both o b e se and lean Zucker rats.

Phosphorylation of nuclear proteins did not increase the binding
Ideally, phosphorylation of the hepatic nuclear proteins from lean and
o b ese Zucker rats should reverse the effects of dephosphorylation on the
formation of the specific DNA-protein complexes. Specifically, it should
increase th e formation of Complexes 1-3 and d e crea se the formation of
Complex 4. In order to verify if this w as the case, PKA, a cAM P-dependent
protein Serine/Threonine kinase, w as used to phosphorylate the hepatic
nuclear proteins from o b e se and lean Zucker rats. It w as added into the
binding reactions and incubated for 30 min just before the addition of labeled
222 bp DNA fragm ent to initiate the binding. But, a s indicated in Figure 17,
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Figure 16. Effect of dephosphorylation on band shift pattern with the 222 bp
fragment. Hepatic nuclear extracts prepared from o b e se and lean Zucker
rats that had been treated with specified am ount of CIAP w ere incubated
with 32P-labeled DNA fragm ents containing the -712 bp to -491 bp region of
ME gene. DNA-protein complexes w ere size fractionated in nondenaturing
polyacrylamide gels and w ere detected by autoradiography. The arrows on
the right indicate the positions of the shifted complexes. +: present, -: absent,
O: obese, L: lean.
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Figure 17. Effect of PKA treatm ent on band shift pattern with the 222 bp
fragment. Hepatic nuclear extracts prepared from o b ese and lean Zucker
rats that had been treated with specified am ount of PKA were incubated with
32P-labeled DNA fragm ents containing the -712 bp to -491 bp region of ME
g ene. DNA-protein com plexes were size fractionated in nondenaturing
polyacrylamide gels and were detected by autoradiography. The arrows
indicate the positions of the shifted complexes. +: present, -: absent, O:
o b ese, L: lean.

75

phosphorylation of the hepatic nuclear proteins with PKA did not change
their binding to the 222 bp DNA fragm ent (lanes 4-11), a s com pared to the
control reactions in which no PKA w as used (lanes 2-3). Lanes 12-15 had no
nuclear proteins and contained different am ount of PKA. No extra bands
other than the free probe w as detected in lanes 12-15, indicating that PKA,
although a protein itself, did not specifically bind to the 222 bp DNA
fragment.
Suspecting that PKA w as not the appropriate protein kinase to
phosphorylate the nuclear proteins involved in the formation of the specific
DNA-protein com plexes in vivo, we explored the effect of phosphorylation of
the hepatic nuclear proteins using PKC, another protein Serine/Threonine
kinase which is activated by phosphatidylserine, diacylglycerol, and C a++.
With the addition of PKC in the binding reactions, phosphatidylserine and
diacylglycerol, which w ere incubated with PKC for activation, w ere also
p resent in the binding reactions. One DNA-protein complex w as se en when
the PKC treated hepatic nuclear proteins from o b ese and lean Zucker rats
w ere incubated with the labeled 222 bp DNA fragment. The intensity of the
complex w as higher when the nuclear proteins from o b ese anim als were
used than when those from lean animals w ere used, which w as consistent
with the result displayed in complex 1 when no diacylglycerol were included
in the binding reaction (Figure 11). However, when PKC w as included in the
binding reactions, the DNA-protein complexes formed by the binding to the
222 bp DNA fragm ent by the hepatic nuclear proteins from both o b e se and
lean Zucker rats w ere dramatically reduced (lanes 4-5 in Figure 18). PKC
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Figure 18. Effect of PKC treatm ent on band shift a ssa y with the 222 bp
fragment. Hepatic nuclear extracts prepared from o b e se and lean Zucker
rats that had been treated with specified am ount of PKC w ere incubated with
32P-labeled DNA fragm ents containing the -712 bp to -491 bp region of ME
g en e. DNA-protein com plexes were size fractionated in nondenaturing
polyacrylamide gels and were detected by autoradiography. The arrow on
the right indicates the position of the shifted complex. +: present, absent,
O: o b ese, L: lean.
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itself w as shown not to bind to the labeled target DNA in lane 6, in which on
nuclear proteins w ere added.

Binding of nuclear proteins to different regions of the 222 bp fragment
In order to further investigate the roles the different regions of the 222
bp DNA fragm ent played in the formation of the DNA-protein com plexes, we
obtained two sm aller DNA fragments, which together constitute the whole
222 bp upstream region of ME gene (Figure 1), by digesting pME222 with
th e restriction enzym es EcoRI and PfIMI. The resulting 70 bp (containing the
HNF3 binding site and the IRE-I site) and 152 bp (containing the GRE site
and TATA box) DNA fragm ents were end labeled with [a-32P]dATP using
Klenow fragment.
The binding of the hepatic nuclear proteins from both o b e se and lean
Zucker rats to the 70 bp DNA fragment (-712 to -643) resulted in up to six
DNA-protein com plexes (Figure 19). The formation of the Com plexes 1-2
w ere so w eak that they appeared a s two sm ears rather than two bands
(lanes 1-2 in Figure 19). In spite of the weak binding, dephosphorylation of
the nuclear proteins with CIAP completely abolished the already w eak
formation of the DNA-protein complex (lanes 4-9, Figure 19). The formation
of Complex 3 w as also reduced by the dephosphorylation of the nuclear
proteins from both o b ese and lean rats. In contrast, Com plexes 5-7 w ere
found increased by the sam e treatm ent. Interestingly, another band, nam ed
Complex 4, appeared with the dephosphorylation of the nuclear proteins and
its intensity increased a s the amount of CIAP w as used. In all c a se s, the
formation of Com plexes 1-3 were stronger in obese anim als than in lean
anim als when sam e am ount of CIAP w ere used.
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Figure 19. Effect of dephosphorylation and adrenalectom y on band shift
pattern with the 70 bp fragment. Hepatic nuclear extracts prepared from
o b e se and lean Zucker rats that had been treated with specified am ount of
CIAP (lanes 2-9) or those from o b ese and lean Zucker rats that had been
adrenalectom ized, adrenalectom ized and dexam ethasone treated, or sham
operated (lanes 10-15) were incubated with 32P-labeled DNA fragm ents
containing the -712 bp to -643 bp region of ME gene. DNA-protein
com plexes w ere size fractionated in nondenaturing polyacrylamide gels and
w ere detected by autoradiography. The arrows on the arrows on the right
indicate the positions of the shifted complexes. +: present, -: absent, O:
ob ese, L: lean, S: sham , A: adrenalectomy, D: dexam ethasone.
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The effects of adrenalectom y of the rats on the binding of the nuclear
proteins to this 70 bp DNA fragment were also explored. Although there is no
GRE site in this region, the formation of the Com plexes 1-3 w ere still
inhibited by adrenalectom y of both o b e se and lean Zucker rats (lanes 12-13
in Figure 19). This treatm ent had an opposite effect on the formation of
Com plexes 4-5. Higher am ounts of Com plexes 1-3 w ere formed with
extracts from o b ese animals than from lean animals, while the formation of
C om plexes 5-7 w ere more prominent in lean anim als than in o b ese animals.
W hen hepatic nuclear proteins from dexam ethasone replaced o b ese
and lean Zucker rats were incubated with the 70 bp DNA fragment, the
intensities of Com plexes 1-3 w ere dramatically increased and the formation
of com plexes 5-7 w as greatly reduced com pared with those in
adrenalectom ized rats. Again, the levels of Com plexes 1-3 w ere higher in
o b e se anim als than in lean anim als and the levels of Com plexes 5-7 w ere
higher in lean anim als than in o b ese animals.
W hen the 152 bp DNA fragment (-642 to -491) w as used a s the target
DNA in band shift assay s, up to five bands show ed up and there w ere more
nuclear proteins from o b ese Zucker rats that bound to the 152 bp DNA than
from lean Zucker rats (lanes 2-3 in Figure 20). As increasing am ounts of
CIAP w ere added in the binding reactions, Com plexes 1-2 gradually
disappeared and the formation of Com plexes 3-5 were increased (lanes 4-9
in Figure 20). W hen the sam e am ounts of CIAP were added, the formation of
Com plexes 3-5 w ere found to be formed in larger am ounts in lean anim als
than in o b e se animals.
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Figure 20. Effect of dephosphorylation on band shift pattern with the 152 bp
fragment. Hepatic nuclear extracts prepared from o b e se and lean Zucker
rats that had been treated with specified am ount of CIAP w ere incubated
with 32P-labeled DNA fragm ents containing the -642 bp to -491 bp region of
ME gene. DNA-protein complexes were size fractionated in nondenaturing
polyacrylamide gels and w ere detected by autoradiography. The arrows on
the right indicate the positions of the shifted complexes. +: present, -: absent,
O: o b ese, L: lean.
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BuGR2 reduced the binding of hepatic nuclear proteins to the 222 bp
fragment
Since the glucocorticoid status in o b e se and lean Zucker rats show ed
a dram atic influence on the binding of the hepatic nuclear proteins to the 222
bp DNA fragment, which contains a GRE, it w as of value to investigate
w hether the glucocorticoid receptor exists in the DNA-protein com plexes
formed in the band shift assay s. In one of the band shift a ssa y s, we treated
the hepatic nuclear extracts from o b ese Zucker rats with 10 units of BuGR2
before the binding reaction took place (lane 3 in Figure 21). Generally the
binding of hepatic nuclear proteins to this 222 bp DNA fragm ent w as
considerably reduced by th e inclusion of the BuGR2 in the binding reaction.
This d e crea se in binding can be observed in the formation of all the DNAprotein com plexes. Interestingly, a very faint band show ed up at th e position
slightly below the well. This relatively faint band could not be cau sed by the
binding of the BuGR2 antibody to the labeled 222 bp DNA fragm ent b e ca u se
incubation of BuGR2 with only the labeled probe show ed no shifted band
(data not shown).
Lanes 4-6 in Figure 21 show s the effect of different am ount of BuGR2
on the formation of the DNA-protein com plexes. As the am ount of BuGR2
included in the binding reactions w as increased (0.1, 1 ,2 units), the
formation of the DNA-protein com plexes d ecreased except the band just
below the well, which might be a super-shifted band.
Therefore, it se em s that the glucocorticoid receptor antibody h a s an
inhibitory effect on the binding of the hepatic nuclear proteins from o b ese
Zucker rats to the 222 bp DNA fragment.
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Figure 21. Effect of GR antibody on band shift a ssay with th e 222 bp
fragment. Hepatic nuclear extracts prepared from o b ese Zucker rats were
incubated with 32P-labeled DNA fragm ents containing the -712 bp to -491 bp
region of ME gene, together with specified am ount of monoclonal antibodies
(BuGR2) against GR. DNA-protein com plexes were size fractionated in
nondenaturing polyacrylamide gels and w ere detected by autoradiography.
The arrows on the right indicate the positions of the shifted com plexes. +:
present, absent, O: obese, L: lean.
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Effects of the anti>HNF3a antiserum on the binding of hepatic nuclear
proteins to the 222 bp DNA fragment
Since the 222 bp DNA fragment also contains an HNF3 binding site
and the binding of the hepatic nuclear proteins from o b ese and lean Zucker
rats w ere significantly affected by the phosphorylation status of the nuclear
proteins, we looked into the effect of the treatm ent of the hepatic nuclear
proteins with the anti-HNF3a antiserum on the formation of the DNA-protein
com plexes (Figure 22).
Surprisingly, when the anti-HNF3a antiserum w as included in the
binding reactions, two extra bands (Complexes a, b) w ere se e n (lanes 4-5 in
Figure 22) com pared with the band shift a ssa y s carried out with only the
labeled probe and the hepatic nuclear proteins from o b ese (lane 2 in Figure
22) and lean (lane 3 in Figure 22) Zucker rats. There w as m ore Complex a
formed by obese nuclear extract then by lean nuclear extract. In contrast,
there w as more of Complex b formed by lean nuclear extract than by o b e se
nuclear extract.
The formation of the four DNA-protein com plexes by the binding of
nuclear proteins not treated with the anti-HNF3a antiserum w ere still
observed when the band shift a ssa y s were performed with the inclusion of
the antiserum. The patterns and intensities of three of th ese bands
(Com plexes 1, 2, and 4) w ere not significantly affected when the nuclear
proteins w ere treated with the antiserum.
The most significant change caused by the treatm ent with the antiHNF3a antiserum w as the dramatic increase of the intensity of Complex 3.
However, there w as still m ore Complex 3 formed by the o b e se nuclear
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Figure 22. Effect of HNF3 Ab on band shift pattern with the 222 bp fragment.
Hepatic nuclear extracts prepared from o b ese and lean Zucker rats were
incubated with 32P-labeled DNA fragm ents containing the -712 bp to -491 bp
region of ME gene, together with or without polyclonal antiserum against
HNF3a. DNA-protein com plexes were size fractionated in nondenaturing
polyacrylamide gels and were detected by autoradiography. The arrows on
th e right indicate the positions of the shifted complexes. +: present, absent,
O: obese, L: lean.
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extracts (lane 4 in Figure 22) than that formed by the lean nuclear extracts
(lane 5 in Figure 22).
It s e e m s that the anti-HNF3a antiserum increased the binding of the
hepatic nuclear proteins from o b ese and lean Zucker rats to the 222 bp DNA
fragm ent b e ca u se there w as much less free labeled probe left when the
antiserum w as used in the binding reaction.

SDS PAGE analysis of proteins in DNA-protein complexes from band
shift assays
In order to analyze the proteins present in the Complex 1 in Figure 11,
15 fold scale-up band shift a ssa y s were performed with the 222 bp DNA
fragm ent a s labeled probe. Two control reactions w ere run without any target
DNA. After exposure to the X-ray films, the original gels w ere aligned with
the X-ray films and the gel slices at the sam e position a s Complex 1 were
excised. The proteins in the excised gel slices w ere eluted and subjected to
4-20% SDS-PAGE analysis. As shown in Figure 23, there w ere at least 3
proteins in Complex 1 formed by the binding of hepatic nuclear proteins to
the 222 bp DNA fragment (lanes 2 and 4). The sizes of the proteins were
approximately 123 kd, 67 kd, and 31 kd. There were larger am ount of
proteins in Complex 1 from o b e se animal (lane 2) than that from lean animal
(lane 4). The protein complex in the unbound nuclear extracts which h a s the
sam e migration rate a s the DNA-protein Complex 1 se em s to contain m ore
proteins of smaller sizes than Complex 1 (lanes 1 and 3 in Figure 23). A
protein with a M.W. of approximately 33 kd w as present in the unbound lean
protein complex and absent from the unbound o b ese protein complex.
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Figure 23. SDS PAGE of Complex 1. The DNA-protein complex 1 indicated
in Figure 11 w ere isolated from a 15 fold scale-up reaction and subjected to
SDS-PAGE analysis. The protein com plexes from the sam e position in the
band shift a ssa y s perfomed without adding any DNA w ere also obtained and
analyzed. Lane 1, o b e se nuclear proteins at the sam e position of Complex 1.
Lane 2, o b e se Complex 1. Lane 3, lean nuclear proteins at the sam e
position of Complex 1. Lane 4, lean Complex 1. Lane 5, protein marker. The
protein bands refered in the text w ere indicated by the arrows.
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Analysis of the hepatic nuclear proteins using polyacrylamide gel
electrophoresis
Identification of the proteins that are apparently present at higher or
lower levels in, or even absent from, the o b ese rat hepatic nuclei and
information of their function and regulation may provide insight into the
abnormal responsiveness of certain gen es to glucocorticoid in the o b e se rat.

SDS PAGE
SDS PAGE of the hepatic nuclear proteins from o b e se and lean
Zucker rats show ed a large num ber of bands with a wide range of molecular
sizes (Figure 24). No obvious differences were observed in the gel patterns
of the o b e se (lane 2) and lean (lane 3) hepatic nuclear extracts. They both
have the sam e num ber of bands with approximately identical intensities.

2=D.PA<3E
Since no obvious differences were detected betw een the nuclear
protein profiles of o b ese and lean Zucker rats using SDS-PAGE, the nuclear
proteins w ere subjected.to 2-D PAGE, which has a much higher resolving
power in detecting individual proteins or polypeptides.
2-D PAGE analysis of the hepatic nuclear extracts from o b e se and
lean Zucker rats show ed that the overall composition of nuclear protein
profiles were generally similar (Figure 25) except that there w ere two extra
spots in lean nuclear extract which were absent from the o b e se nuclear
extract (Figure 25-26). They have the sam e pi which is 5.2. Their M.W. were
approximately 31 kd and 32 kd, respectively. Attempting to characterize
th e se proteins, the protein spots which had been transfered from the gels to
the PVDF m em branes w ere isolated for sequencing analysis. Unfortunately,

Figure 24. SDS PAGE of nuclear proteins from o b ese and lean Zucker Rats.
Hepatic nuclear extracts prepared from o b ese and lean Zucker rats w ere
analyzed using an 8% SDS-PAGE. Lane 1, lean nuclear extract. Lane 2,
o b e se nuclear extract. Lane 3, protein marker.
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Figure 25. 2-D PAGE of hepatic nuclear proteins from lean and o b e se
Zucker rats. A, lean nuclear extract; B, o b e se nuclear extract. The 2-D PAGE
w ere performed a s described in the Materials and Methods. The two spots
(31 and 32 kd respectively) in lean nuclear extract are pointed by the left
arrows. The right arrows indicate the position of the internal m arker
tropomyosin.
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Figure 26. A close up look at the 2-D PAGE of hepatic nuclear proteins from
lean and o b ese Zucker rats. Legends are the sam e a s in Figure 25.
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the N-terminals of th ese two proteins were blocked and the se q u en c es of
them could not be obtained.

DISCUSSION

Our initial band shift a ssa y s performed with five DNA fragm ents which
cover the entire 882-bp upstream region of the ME g en e show ed that
generally larger am ounts of specific DNA-protein com plexes were formed
when hepatic nuclear proteins from o b ese rats were used in com parison to
hepatic nuclear proteins from lean rats (Figures 9-10, 12-14).
Bray and York (118) have previously shown that the hepatic and
adipose mRNA levels for ME and GAPDH were increased in young o b ese
falfa rats. Our results from the band shift a ssa y s indicated alteration in
binding of proteins to the upstream region of ME gene. T hese may contribute
to the increase of ME transcription shown by Je n se n et al. (261).
The upstream region of the rat ME g en e has many known binding
sites (Figure 1) for transcription factors, m any of which have been well
studied (Table 2). T hese protein binding sites have been found to exist in
m any eukaryotic g e n es that are under the control of multiple horm ones
(262).

The binding of hepatic nuclear proteins to the 134 bp fragment
Up to seven DNA-protein com plexes w ere detected in the band shift
a ssa y using the 134 bp DNA fragment a s target DNA and hepatic nuclear
extracts from o b e se and lean Zucker rats a s proteins (Figure 9). This is not
surprising b e c a u se the DNA seq u en ces in the 134 bp fragm ent used in band
shift a ssa y s is located around the cap site (-102 to +33) and have been
shown to be bound by many hepatic nuclear proteins (249). The function of
this region se em s to account for th e basal expression of the ME gene, which
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h as been suggested to be one of the constitutive or "house keeping" g e n e s
(263).
Morioka et al. have found a 10-bp direct repeat of the seq u en c e 5'CTCGCCACCC-3' betw een -73 and -51, separated by 3 bp. Using D N ase I
footprint analysis Petty et al. have been able to dem onstrate that each copy
of the repeated seq u en ce w as bound by a sep arate se t of proteins (249).
Deletion mutation experim ents and transcription competition analysis also
show ed that this direct repeat is important to maintain the basal
transcriptional activity of the ME gene (249). Although the function of this
rarely se e n direct rep eat is still not clearly understood, it has been shown to
b e bound by rat hepatic nuclear proteins in a thyroidal status dependent
m anner (249). It is possible that the nuclear proteins which bind to this direct
rep eat are required for the assem bly of the specific transcription initiation
complex for the ME gene.
Three of the nine CCGCCC hexanucleotide boxes p o sse sse d by the
ME gene, which have been speculated to be involved in th e chromatin
assem bly required for g en e expression, were also found to be in this 134
seq u en ce (245). Moreover, it h as been reported that the se q u en c es betw een
-29 and +28 in this region were protected from DNase I in the footprinting
experim ent and w ere essential for the basal transcription activity, indicating
that it might be bound by the transcription initiation complex or som e of its
com ponents.
Therefore the seven bands observed in the band shift a ssa y
performed with the 134 bp DNA fragment might represent DNA-protein
com plexes formed by several different transcription factors or by different
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combinations of several transcription factors involved in the transcription
initiation.
Band shift a ssa y s performed by other researchers show ed that m ost
of the se q u e n c e s in the 134 bp region were similarly bound by hepatic
nuclear proteins from hypothyroid, euthyroid, and hyperthyroid rats, except
the direct repeat to which the binding of rat hepatic nuclear proteins w as
d ep en d en t on the thyroidal status of the rats (249). Although the o b e se
Zucker rats are generally considered to be in a mild hypothyroid state (69),
we did not observe any significant differences betw een the levels at which
the 134 bp DNA fragm ent w as bound by the hepatic nuclear proteins from
o b e se and lean Zucker rats. This may result from the interaction betw een the
nuclear proteins that bind to the direct repeat and those that are positively
regulated by glucocorticoids or insulin since o b ese Zucker rats, a s h as been
m entioned above, are hyperresponsive to the effect of glucocorticoids and
have a higher level of hepatic ME mRNA com pared with lean Zucker rats
(118). It h as also been shown that insulin increases the rat hepatic mRNA
levels even in the a b se n c e of thyroid hormone, w hereas the thyroid horm one
w as not able to increase the hepatic mRNA levels in the a b se n c e or low
levels of insulin (230).
Although the se q u e n c e s from +1 to -41 have been shown to be
sufficient to initiate expression of the ME gene, the region +1 to -102 is not
enough for maximal prom oter activity (245). S eq u en ces further upstream are
involved in transcriptional regulation of the ME g en e by a num ber of nuclear
proteins.
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The binding of hepatic nuclear proteins to the 385 bp fragment
The band shift a ssay performed with the 385 bp DNA fragment
yielded four distinct bands (Figure 10).
Located at -103 to -488, the 385 bp DNA fragm ent contains a num ber
of binding sites for transcription factors and nuclear proteins known to be
important in the regulation of transcription activity of a variety of gen es
(Figure 1, Table 2).

AP-1 binding site
The AP-1 (activator protein-1), initially described a s a DNA-binding
protein in Hela cell extracts (264), has been shown to be bound by Jun-Jun
or Jun-Fos dimers (265). Studies performed by Diamond et al. (266) have
dem onstrated that the changes in th e ratio of Fos to Jun proteins in the AP1
complex could shift the glucocorticoid regulation of the m ouse proliferin gen e
from positive to negative. It has also been shown by other researchers (267)
that different cell-specific environments could result in different interactions
of the GR with the Jun and Fos proteins, which in turn could manifest
different functions.
c-Jun has been shown to p o ssess a glutamine-rich activation domain
th at could interact with other DNA binding proteins such a s the sterol
resp o n se elem ent binding protein (268). Coincidently Sp1, a s will be
discussed below, also contains a glutamine-rich region in its amino-terminal
domain which might be involved in the interaction with other transcription
factors (269).

Sp1 and IRE-II
As a result of enhanced parasym pathetic drive to the pancreatic p
cells, insulin secretion is dramatically increased in the o b e se faffa rat (46,
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106, 270-271). The resulting high insulin level in o b e se rats might directly
increase the binding of certain nuclear proteins to the IREs in m any gene
promoters. IRE-II in the 385 bp DNA fragment is a positive insulin response
elem ent similar to the GAPDH gene promoter IRE-A (224) a s h a s been
shown by G arcia-Jim enez et al. (230) It overlaps the Sp1 elem ent in the
sa m e region (Figure 1, Table 2). It has been suggested that insulin might
en h an ce the expression of ME gene by interacting with the Sp1 protein and
subsequently inducing the binding of the 95 kd and 105 kd Sp1 species
(230).
Sp1 is a transcription factor with the unusual property of activating
TATA-less prom oters (272). The g en e for Sp1 w as cloned in 1987 (273), a
year after it w as purified to homogeneity and biochemically characterized
(274). The Sp1 elem ent which it recognizes (Table 2) exists singly or multiply
in a vast array of cellular and viral promoters (269), including the ME g en e
prom oter used in this study. Sp1 p o sse sse s a glutamine-rich region in its
amino-terminal domain which may interact with other transcription factors.
In a reconstitution study performed in 1990 (272), Pugh and Tjian
provided evidence for the existence of "coactivators" which are required for
Sp1 activation of transcription. Moreover, by comparing the TFIID
requirem ent at TATA containing promoters and TATA-less prom oters, they
w ere able to dem onstrate the presence of an additional "tethering" activity
distinct from the above mentioned coactivators. They proposed that the
tethering activity might interact with both Sp1 and other transcription factors
such a s the TATA binding protein and assist the formation of the basal
transcription initiation complex at the TATA-less promoters (272).
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Although a seq u en ce similar to TATA box h as been found at -621 to 626 of the ME gene, w hether it really functions a s a TATA box is
questionable b e ca u se a TATA box with a position this far from the
transcription start site is very rare. Thus it se em s more appropriate to classify
the ME gen e promoter a s a TATA-less promoter.
Therefore it is very likely that Sp1 and/or the IRE-II binding proteins
224) might participate in the formation of one or more of the four DNAprotein com plexes detected in the band shift a ssa y performed with the 385
bp DNA fragm ent (Figure 10).
As will be discussed below, binding of hepatic nuclear proteins from
o b e se and lean rats to a 222 bp DNA, which locates just upstream of the 385
bp region, requires proper phosphorylation of the nuclear proteins.
Sp1 h a s also been shown to have the ability to cooperate with the sterol
regulatory element-binding protein in sterol regulation of certain g e n es such
a s the low density lipoprotein receptor g en e (269).
TRE
The regulation of ME gene expression by thyroid horm ones h as been
extensively studied by V. M. Nikodem's group, the sam e group which
conducted molecular cloning and structure characterization of the ME gen e
(235, 245, 249, 268).
It h a s been dem onstrated that the thyroid horm one increases the level
of ME mRNA in rat livers by both transcriptional activation and stabilization of
malic enzym e mRNA precursor (275). Concomitantly, a TRE in the ME gen e
w as identified (248) and functionally characterized (276).
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The binding to the AP-1 site on the 385 bp DNA fragm ent by hepatic
nuclear proteins from euthyroid rats w as higher com pared to the hypothyroid
rats and much lower if com pared to the hyperthyroid rats. As h as been
m entioned above, the thyroidal status h as a similar effect on the binding to
the unique direct repeat on the 134 bp DNA fragm ent by the rat hepatic
nuclear proteins (249). This indicates that the thyroid hormone receptors,
which are the cellular analogues of the viral erbA oncogene (277), might
som ehow interact with c-Jun protein and the nuclear proteins that bind to the
10 bp direct repeat in the 134 bp fragment. The fact that th ese three
elem ents lie close to each other supports this view (Figure 1). Moreover, the
thyroid horm one receptor has also been shown to interact with com ponents
of the transcription initiation machinery such a s TFIIB (278) and TATA
binding protein (279).
Therefore the four bands shown in lanes 2 and 3 in Figure 10 might
represent the DNA-protein complexes formed through the binding to the cisacting elem ents by the above mentioned transcription factors or nuclear
proteins. W hether the DNA-protein com plexes are formed by one or more
proteins is not clear.
An obvious difference betw een the 134 bp and 385 bp DNA
fragm ents is that the latter w as bound by the hepatic nuclear proteins from
o b e se rats in a greater extent than by those from lean rats (Figure 10), while
th ere w as no significant difference in the binding to the other. This might
result from increased binding of insulin related factors to the IRE-!I/Sp1 site
in o b e se Zucker rats. Other nuclear proteins which positively regulate ME
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g e n e expression might also participate in the formation of th ese specific
DNA-protein complexes.

The binding of hepatic nuclear proteins to the 222 bp fragment
A distinctive feature of the 222 bp DNA fragm ent is that the patterns in
which the hepatic nuclear proteins bind to it are different betw een o b e se and
lean Zucker rats (Figure 11). This difference could result from differential
binding to the 222 bp DNA fragm ent by a single transcription factor or a
combination of interactions am ong many transcription factors that bind to this
or even other regions of the ME g en e promoter.

GRE
The 3' end of the 222 bp DNA fragm ent contains an imperfect GRE
(Figure 1, Table 2). W hether this GRE in the ME gene is really bound by
glucocorticoid receptor h as not been confirmed by experim ents. Being a
partially palindromic seq u en ce, the GRE can be bound by either m onom ers
or dimers of the glucocorticoid receptor (173-175). The binding to the GRE
by the receptor dimers is cooperative (173-175). As has been m entioned in
the Review of Literature, the glucocorticoid receptor binds to the GRE with its
"zinc fingers" which are located in th e DNA binding domain of the GR
protein. Many nuclear proteins have been found to have a synergistic effect
on the transcriptional activity of the GR. It's suggested that they m ay serve to
"bridge" receptors to the transcription machinery (262). Therefore the GR
m ay participate, through interaction with other nuclear proteins, in the
formation of one or more specific DNA-protein com plexes observed in the
band shift a ssa y performed with the 222 bp DNA fragment.
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TATA
The TATA box in the 222 bp DNA fragm ent d o es not seem to really
function in the initiation complex of transcription since its position is too far
from the traditional TATA box, which is always located close to the
transcription start site. But the possibility that it might som ehow be involved
in transcription can not b e ruled out b ecau se no experim ents have been
performed to investigate its function.

HNF3 and IRE-I
In contrast to the positive IRE-II at -162 to -169 in the 385 bp DNA
fragment, the IRE-I at -693 to -687 in the 222 bp DNA fragm ent resem bles
th e PEPCK promoter IRE (230), the binding to which by a hepatic nuclear
protein h as been shown to be negatively regulated by insulin (230). Unlike
the PEPCK IRE, which overlaps the AF2 elem ent of a com posite GRE unit
(230), the IRE-I in the 222 bp DNA fragment is separated from the GRE
(Figure 1, Table 2). However, it overlaps a potential binding site for HNF3
proteins (Figure 1, Table 2).
The HNF3 family of proteins w ere originally identified a s transcription
factors that bind to prom oters and enhancers of several liver specific g e n es
and coordinated regulated their expression (280). Later th ese proteins w ere
found to play important roles in em bryogenesis when body axis formation
and commitment to different developmental fates are decided (281). The
HNF3 family consists of three proteins (a, p, and y) which sh are strong
homology in DNA binding dom ains that bind to the sam e DNA sequence.
There are three more regions that are homologous am ong them, one in the
amino term inus and two in the carboxyl terminus (282). Moreover, HNF3
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proteins w ere also dem onstrated to be hom ologous with the Drosophila
homeotic g en e fork head (282). A possible reason for the existence of three
related but different HNF3 proteins is that they could be differentially
modified in response to various signals (280). Thus one possible explanation
for the observation that the patterns in which hepatic nuclear proteins bind to
the 222 bp region are different betw een o b e se and lean rats is that the ratios
of different HNF3 proteins binding to this region are different betw een them.
The overlapping of the IRE-I and HNF3 binding site at the 222 region
might indicate that the binding by one nuclear protein interferes with that of
the other. It is possible that one or more DNA-protein com plexes detected in
Figure 11 might result from the retro-excluding binding by the HNF3 proteins
and IRE-1 binding proteins.

The binding of hepatic nuclear proteins to the 186 bp fragment
Located at -696 to -882, far from the transcription start site, the 186
bp DNA fragm ent contains no binding sites for known transcription factors or
nuclear proteins (Figure 1). However, our results clearly indicated that this
region of the ME g en e is bound by certain nuclear proteins since at least two
specific DNA-proteins com plexes were formed when the 186 bp DNA
fragm ent w as incubated with the hepatic nuclear proteins from o b e se and
lean Zucker rats (Figure 12).
The levels of binding by the nuclear proteins from o b ese and lean
Zucker rats to the 186 bp DNA fragm ent are different. However the overall
patterns of the binding are the sam e betw een o b e se and lean animals.
Therefore this region of the ME enzym e g en e might participate in the
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regulation of the expression of the ME gene, but it d o es not seem to function
a s a primary factor in the pathway of the regulation.
Like other DNA fragm ents from the 882 bp upstream region of ME
gen e, the 186 bp DNA fragment w as bound at a much higher level by o b ese
hepatic nuclear proteins than by lean ones (Figure 12). This might be a
result of interactions among the nuclear proteins that bind the -696 to -882
region and those that bind other regions such a s HNF3 binding site, IRE-I
and the GRE which are all located relatively nearby (Figure 1).

The binding of hepatic nuclear proteins to the 49 bp fragment
The binding to the 49 bp DNA fragment (-463 to -511), which contains
a com plete GRE, resulted a major specific DNA-protein complex which is
m ore prominent in o b ese than in lean rats. B ecause GRE is the only known
c/s-acting elem ent in the 49 bp region (Table 2), it is very likely that this
DNA-protein complex is formed by the binding of GR to the GRE. The higher
level of the complex in o b e se Zucker rats might indicate that o b e se hepatic
nuclear extract contains more GR. This ag rees with the report that W estern
blotting of nuclear protein extract h as shown an increase in GR protein in
nuclei of o b ese Zucker rats (261). If this is the case, GR might contribute to
the formation of the Complex 1 in Figure 11, which resulted from binding of
hepatic nuclear proteins to the 222 bp DNA fragm ent since that complex is
also m ore prominent in o b e se rats than in lean rats.

The effect of adrenalectomy
The function of glucocorticoids in the developm ent of obesity in this
genetic model of obesity h as been investigated in a num ber of w ays in the
p ast few years (46, 90, 106, 115-116, 130). The results of Bray and York
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(118) identified an increase in the mRNA levels of the g e n es for ME and
GAPDH in liver and adipose tissue of o b ese Zucker rats that w as dependent
upon glucocorticoids. T hese increases w ere eliminated by adrenalectomizing
the anim als and then restored by replacem ent d o ses of glucocorticoids. This
led to their initial hypothesis that the fa gen e mutation may result directly or
indirectly in a change in the levels or activity of one or more transcription
factors that m odulate glucocorticoid regulated genes. Such an effect is likely
to be expressed in many tissues. While the majority of studies have
concentrated on glucocorticoid responses in liver and adipose tissue of
o b e se rats, evidence that there are also alterations in the central responses
to the glucocorticoids h a s been presented from several laboratories (283284).
The finding that the o b ese nuclei contain more protein that binds to
DNA in th e -712 to -491 region of ME gene, which contains an HNF3 binding
site, the IRE-I, and an imperfect GRE, and the abolishm ent of the formation
of the DNA-protein complex by adrenalectom y of the Zucker rats (Figure 15),
supports the possibility that there may be alterations in transcription factors
that m odulate glucocorticoid resp o n ses in the o b ese falfa rat.
Cross-talk betw een signal transduction pathw ays has been
recognized a s a common paradigm in cellular developm ent and
hom eostasis. Insulin degrading enzym e (IDE) w as reported to interact with
GR and AR (androgen receptor), which may potential couple insulin and
steroid horm one signaling pathways. This relationship may be important for
various biological phenom ena, such a s insulin resistance, and specificity of
steroid horm one action (285).
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Phosphorylation status
A rapidly growing area of interest in the study of protein
phosphorylation is the regulation of cellular growth through phosphorylation
of key nuclear proteins (286). T hese nuclear proteins include som e
transcription factors such a s CREB (287), Jun, Fos (58, 288-289), NF-kB
(289), Myc (289), and Myb (290-291), and tumor suppressor proteins such
a s pRB (292) and p53 (293-294). Regulation of the activities of th e se
proteins can occur through phosphorylation and dephosphorylation
m echanism s that in turn respond to the timing m echanism of the cell cycle,
or directly to extracellular signals transduced to the nucleus by "cascade
events". In addition, som e viral proteins that stimulate cellular growth are
also regulated by phosphorylation or are able to influence the
phosphorylation of proteins central to growth regulation (285).
All m em bers of the steroid hormone receptor family are
phosphoproteins. On incubation of cells or tissues in culture with the
respective ligands, steroid receptors becom e hyperphosphorylated. This
extraphosphorylation is a rapid process (<30 min) and is associated with
receptor transformation (295-297). But w hether the increase in steroid
receptor phosphorylation upon hormone treatm ent is the consequence of a
conformational change, making the receptor a better substrate for a
kinase(s) or a poorer substrate for a phosphatase(s), is unknown (181).
Our study show ed that certain DNA-protein com plexes formed by
binding of the 222 bp DNA fragment by Zucker rat hepatic nuclear proteins
w ere abolished by dephosphorylation of the nuclear proteins (Figure 16).
This clearly indicates the involvement of protein phosphorylation in the
modification of the transcription regulation of the ME gene. W hen the
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formation of Com plexes 1-3 in Figure 16 w ere abolished by the
dephosphorylation of the nuclear proteins, the formation of Complex 4, w as
promoted. In fact, at least two more DNA-protein com plexes appeared with
similar migration rates to Complex 4. It is likely that the nuclear proteins in
th e se small com plexes represent those which together, when properly
phosphorylated, form the Com plexes 1-3 which m igrates much m ore slowly.
T h ese proteins can still bind to the DNA but they can no longer interact with
each other to form a complicated complex on the DNA fragment.
R ecent studies indicate that cellular kinases play a prominent role in
the regulation of m em bers of the steroid/thyroid horm one receptor
superfamily. PKC (298) and PKA (299) have been implicated to en h an ce the
transcription activation activities of the GR (298). PKA w as also reported to
increase the receptor mRNA (300).
Transcriptional regulation by cAMP occurs through a multistep
p ro cess involving activation of cAMP-dependent PKA and subsequent
phosphorylation of transcription factors such a s cAMP response elem ent
biding protein (CREB) or activating transcription factor-1 which activate
transcription by binding to the cAMP response elem ents (CREs) of target
g e n e (301-302). Several g e n es are coordinated regulated by both
glucocorticoids and cAMP (303-306). Moreover, Rangarajan et al. w ere able
to dem onstrate that PKA m odulates the steroid sensitivity of a target cell by
enhancing the DNA binding activity of GR for GRE (299).
The activity of adenylate cyclase is under control of both stimulatory
and inhibitory horm one receptors. R eceptors for stimulatory horm ones are
coupled to adenylate cyclase via the stimulatory guanine-nucleotide-binding
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protein Gs while the effects of inhibitory receptors are mediated via one or
more of th e inhibitory G proteins: Gi-1, Gi-2 or Gi-3 (161, 307). A loss of Gi
function in hepatocyte m em branes in o b ese Zucker rats but not their lean
counter parts has been reported (308-309). Houslay showed that ligands
which enhanced Gja-2 phosphorylation in intact hepatocytes from lean
Zucker rats failed to do so in hepatocytes from o b ese animals. They
su ggested that this defect in guanine-nucleotide-m ediated "G| function” se en
in o b e se Zucker rats may be due to an inactivating phosphorylation of a G r 2
cau sed by elevated PKC activity (161).
However, in our experiments, treatm ent of Zucker hepatic nuclear
proteins with PKA failed to enhance the binding of the nuclear proteins to the
222 bp DNA fragment (Figure 17). PKC treatm ent of the Zucker hepatic
nuclear proteins did not increase the binding of the hepatic nuclear proteins
to th e 222 bp DNA fragm ent either (Figure 18). In fact it d ecreased the DNAprotein complex formation. This is not surprising b e ca u se the in vivo
phosphorylation of the nuclear proteins is a well regulated, protein specific,
amino acid residue specific, and protein kinase specific process. Therefore
the phosphorylation of the improper nuclear proteins, the phosphorylation of
the right nuclear protein at the improper residues, or over-phosphorylation of
the nuclear proteins would d ecrease the ability of the nuclear proteins to bind
to specific DNA sites (310).
Nevertheless, DNA-dependent phosphorylation h as been suggested
to be a m echanism for transcription activation (311). it has been shown that
Sp1 can be quantitatively and efficiently dephosphorylated by protein
p h o sp h atases, the activities of which do not require the binding of Sp1 to
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DNA and can be inhibited by okadaic acid (312). Thus it is possible that the
dephosphorylation of Sp1 might account partly for the disruption of som e of
the DNA-protein com plexes formed by the binding of the hepatic nuclear
proteins to the 222 bp DNA fragment.

Different regions of the 222 bp DNA fragment
In diabetic rats (type I), ME mRNA w as undetectable but w as
increased by insulin. The transcription rate of the gen e w as also reduced in
the diabetic liver and recovered after insulin therapy (230). Garcia-Jim enez,
et al. found that the protein/IRE-l complex increased in liver nuclear extracts
from diabetic rats and d ecreased after insulin administration, suggesting that
this seq u en ce could m ediate negative regulation by insulin a s h as been
reported by O'Brien (3, 225). In contrast, the protein/IRE-l I complex
d ecreased in liver nuclear extracts from diabetic rats and increased after
insulin administration.
In our study the Complex 1 formed by the 222 bp DNA fragm ent and
nuclear proteins increased in o b ese Zucker rats com pared to those from the
lean Zucker rats. In order to find out if IRE-I is involved in this increase we
used a 70 bp fragment, which contain the overlapping IRE-I and HNF3
binding site, in the band shift a ssa y and the result showed that the binding of
nuclear proteins to this region w as weak in both obese and lean Zucker rats
(Figure 19). This ag re es with Garcia-Jim enez’s report b e cau se the insulin
level is not reduced in either the lean or obese Zucker rats. However
glucocorticoid replacem ent on adrenalectom ized obese and lean Zucker rats
dem onstrated a dramatic increase in binding of nuclear proteins to the 70 bp
region (Figure 19). We suspect the increase in binding w as caused by HNF3
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other than the IRE-I binding protein b ecau se the replacem ent with
dexam ethasone increased the hepatic ME mRNA level in Zucker rats (118);
and proteins of the HNF3 family, the binding sites of which were found to
overlap IRE, have been shown to be required for the full induction of PEPCK
g e n e transcription by glucocorticoids (246). Moreover, th e HNF-3p protein
has b een shown to p o sse ss two casein kinase I and two casein kinase II
phosphorylation sites (313), indicating a putative regulatory role
phosphorylation might play,
However the possibility cannot be ruled out that insulin might indirectly
regulate the glucocorticoid responsiveness of g e n es through modulation of
transcription factor gen e expression, which h a s been shown to be true for
the expression of c-fos (273).
The GRE and IRE/HNF3 binding sites are located fairly close to each
other in the upstream region of ME gene. Our finding that the IRE/HNF3
binding site n e ed s the p resence of GRE or treatm ent of the rats with
glucocorticoids to form the specific DNA-protein complex intrigue us. W e
propose that part of the metabolic changes in fa/fa rats might be cau sed by
th e improper phosphorylation of one or more nuclear proteins which interact
with GR, HNF, and/or insulin related factors to regulate g en e expressions.
The 152 bp DNA fragment derived from the 222 bp region generated
a t least 5 DNA-protein com plexes when bound by hepatic nuclear proteins
from o b e se and lean Zucker rats (Figure 20). The formation of Complex 1 by
o b e se rat nuclear extract w as much stronger than that by lean nuclear
extract. This may due to the presence of the GRE in this region since the
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position of this complex is com parable to the position of Complex 1 in Figure

11.
Com plexes 1 and 2 in Figure 20 were abolished by the
dephosphorylation of the nuclear proteins indicating that the formation of
th e s e two com plexes require the phosphorylation of the involving proteins.
Dephosphorylation of the nuclear proteins se em s to inhibit the interactions
am ong DNA binding proteins giving rise to many sm aller DNA-protein
com plexes that contains fewer nuclear proteins or single protein (i.e.
Com plexes 3-5).

Bu£B2
Our study show ed that formation of specific DNA-proteins com plexes
w ere d ecreased by the BuGR2 antibody (Figure 21), which is directed
against the rat glucocorticoid receptor, indicating that this antibody blocks
the binding of glucocorticoid receptor to its cognate seq u en ce and/or the
interaction of the GR with other transcription factors. This finding further
supports the GR's role in the regulation of the expression of ME gene.
It is not surprising that the BuGR2 antibody blocked the formation of
th e DNA-protein complex instead of binding to the DNA-protein complex and
causing a supershifted band b e ca u se the BuGR2 antibody "has been shown
to react with a single epitope in the DNA-binding domain of the
glucocorticoid receptor". The binding of the antibody to GR might also
change the conformation of the protein and affect its transactivation activity,
which distributes all over the entire GR protein (262).
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Anti-HNF3ot antiserum
In contrast to the inhibitory effect of BuGR2 on the binding to the 222
bp DNA fragment, the treatm ent of the Zucker hepatic nuclear proteins with
anti-HNF3a antiserum actually increased the binding. This increase in
binding might be mediated by the interaction of HNF3a with its antiserum,
which might som ehow changed the conformation of the HNF3a protein,
rendering it able to bind to the DNA. This cannot be caused by the binding of
HNF3a antiserum to the probe since the antiserum alone did not form any
shifted band when incubated with the labeled 222 bp fragm ent (Data not
shown). Future experim ents with monoclonal antibodies or antibodies
against other HNF3 proteins such a s HNF3p may resolve this question.

Proteins in Complex 1
W hen the DNA-protein complex 1 (Figure 11) from a scaled up band
shift a ssa y w ere resolved in SDS PAGE, a protein with a M.W. of 123 kd w as
se en in the com plexes formed with both o b ese and lean hepatic nuclear
extracts (lanes 3 and 5 in Figure 23). A 31 kd protein w as present in the
o b e se Complex 1 w hereas a sm ear around this M.W. range w as se en in the
lean Complex 1, probably indicating the presence of several proteins.
An interesting finding is that when the original hepatic nuclear proteins
w ere run on the non-denaturing PAGE, protein-protein com plexes that have
th e sa m e migration rate a s Complex 1 w ere found to contain different
proteins betw een o b ese and lean rats (lanes 2 and 4 in Figure 23). The
protein-protein complex in o b ese extract has the sam e com ponents a s the
DNA-protein Complex 1. In contrast there w ere clearly one extra protein in
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the protein-protein complex in the lean nuclear extract com pared to the DNAprotein Complex 1. The M.W. of the this protein is 33 kd.
A possible explanation for the a b sen c e of this protein from the DNAprotein complex 1 might be that this small protein interacts with the larger
proteins to form protein-protein com plexes in the lean nuclear extracts.
W hen the target DNA w as available, the small protein may dissociate from
the larger proteins and bind to the target DNA to form small DNA-protein
com plexes such a s Complex 4 in Figure 11. The larger proteins also bind to
the target DNA but the larger protein them selves have a lower concentration
in lean extracts com pared with the o b ese extracts. The possibility that the
a b sen c e of this 33 kd protein from the o b ese nuclear extract represent the fa
defect is very appealing.

SDS PAGE of the original nuclear extracts
The SDS PAGE of the original nuclear extracts from obese and lean
Zucker rats dem onstrated a similar overall pattern (Figure 24). No extra
b ands w ere se en in either the hepatic nuclear extracts or the lean ones. The
concentration of m ost of the proteins that can be resolved show ed an
obvious increase in hepatic nuclear extracts from the o b e se Zucker rats
com pared to those from the lean ones (Figure 24).

2-D PAGE of the original nuclear extracts
Since its introduction in 1975 by O'Farrell et al. (260), high-resolution
two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(2D-PAGE) of proteins has been used to exam ine a wide variety of biological
system s. It is unm atched by any other technique for simultaneously resolving
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hundreds of polypeptides. The application of this method has been
docum ented in thousands of publications (314).
The nucleus, the site of DNA replication and differential g en e
expression, is one of the major subcellular organelles that are critically
involved in cellular proliferation and differentiation (315). The nucleus is an
extremely complex structure containing DNA, RNA, and about 5-15% of the
total cellular protein according to the particular cell type. In general, nuclear
proteins include histone proteins which are relatively basic and generally
asso ciated with DNA, and nonhistone proteins which are highly complex and
heterogeneous, relatively acidic, and associated with all subnuclear
com ponents. The functions of nonhistone proteins range from structural,
enzymatic, to gene regulatory functions. The nonhistone proteins include
nucleoskeletal proteins (316), RNA splicing and transport proteins, seq u en ce
specific DNA-binding proteins (317), hormone and growth factor receptor
m olecules (318), oncogene and tumor suppressor proteins (319), protein
k inases and p hosphatases (320), transcriptional activators and repressors
(321), coactivators, adaptors, and accessory proteins (322).
With the developm ent of high resolution 2-D PAGE many reports have
ap p eared describing detailed analysis of nuclear associated polypeptides
from both normal and transformed cell lines and whole tissue sam ples.
Detailed rat liver epithelial cell nuclear protein d a tab ase has been
established (315). The 2-D PAGE study of differential polypeptide
expression in adipose tissue of lean and o b ese Zucker rats performed by
Laurent-Winter et al. showed an increase in the accumulation of several
peptides in the adipose tissue of o b ese rats at 30 days of ag e (323).
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However 2-D PAGE information about the nuclear proteins from Zucker rats
h as not been reported before our study.
Although the SDS PAGE of the nuclear extracts show ed an increase
of the concentration of m ost of the proteins in the o b ese rats, the result from
the 2-D PAGE (Figure 25-26) show ed two spots in the hepatic nuclear
extracts from the lean Zucker rats. T hese two proteins have a pi of 5.4 and
their M.W. are approximately 31 kd and 32 kd, respectively. The fact that
they are N-terminal blocked is not surprising b ecau se this happens with m ost
of th e eukaryotic nuclear proteins.
Since the falfa rats are supposed to have a defect in the function of
the receptor for the ob gene product, it is possible that the a b sen c e of the
two proteins in the falfa nuclear extracts might represent the impairment of
the receptor for the ob gene product.
Interestingly, the difference betw een the M.W. of th ese two proteins
(31 kd and 32 kd) and that of the small protein in the protein-protein complex
with the sam e migration rate a s the DNA-protein Complex 1's (33 kd) is
practically ignorable b ecau se th e se data were obtained from different PAGE
with different molecular weight standard and m easuring errors can easily
c au se such a difference. Thus, the 33 kd protein absent from o b ese nuclei is
like the sam e a s the 31 and 32 kd proteins shown absent from the 2-D
PAGE. Future investigation n eed s to be conducted to further characterize
th e se proteins.

SUMMARY

The binding of proteins from hepatic nuclear extracts of lean and
o b e se Zucker rats to the upstream region of the gene for one of the
glucocorticoid-dependent enzym es h as been tested using band shift a ssa y s.
DNA fragm ents from the upstream region of the malic enzym e g e n e w ere
u sed a s target DNAs. Nuclear extracts were prepared from young lean and
o b e se Zucker rats (4-6 w eeks old).
An increase in binding of nuclear proteins to the upstream region of
ME g en e w as observed in nuclear extracts from o b ese rats. The specificity of
the binding w as dem onstrated by adding e x cess am ount of either unlabeled
target DNA or unrelated DNA in the binding reaction.
A 222 bp DNA fragm ent (-712 to -491) from the upstream region of
ME g en e w as found to b e bound in different patterns by the hepatic nuclear
proteins from obese and lean Zucker rats. A large DNA-protein complex w as
found to be more prominent in o b ese rats than in lean rats, while other DNAprotein com plexes were more prominent in lean rats than in o b ese rats.
Adrenalectomy reduced a specific DNA-protein complex formation
and glucocorticoid replacem ent restored the specific DNA-protein complex
formation in both lean and o b e se rats.
Alkaline phosphatase treatm ent of the nuclear proteins reduced the
specific DNA-protein complex formed with the 222 bp DNA of ME g en e in
both o b e se and lean rats.
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A monoclonal antibody against glucocorticoid receptor w as found to
interfere with the formation of a large specific DNA-protein complex when the
222 bp DNA fragment w as used.
2-D PAGE of the nuclear proteins from o b ese and lean rats showed
that there w ere two proteins present in lean nuclear extract but ab sen t from
o b ese nuclear extract.

CONCLUSION AND PERSPECTIVES

Differences in nuclear proteins binding to the upstream region of ME
g e n e betw een lean and o b e se Zucker rats may reflect changes in
phosphorylation state of the nuclear proteins. Glucocorticoid receptor se e m s
to be involved in the regulation of the phosphorylation status of the nuclear
proteins.
Cloning of the Fa gene will provide invaluable information in the
obesity study. However, how the product of Fa gene interacts with the signal
transduction pathw ays and regulates gene expression needs to be clarified
before the m echanism s of the developm ent of obesity syndrom e can be fully
understood.
The purification and characterization of the two nuclear proteins in
lean Zucker rats that are ab sen t from o b ese Zucker rats may provide insights
into the influence of the Fa gen e product on the composition and functions of
the nuclear proteins.
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APPENDIXES

A. Quantitation of Complex 1-3 in lanes 2-3 in figure 9
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C. Quantitation of Complex 1-4 in lanes 2-3 in figure 11
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D. Quantitation of Complex 1 in lanes 2-3 in figure 12
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E. Quantitation of the DNA-protein complexes in lanes 2-3 in figure 14
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F. Quantitation of Complex 1 in lanes 2-7 in figure 15
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G. Quantitation of Complex 1 in lanes 2-13 in figure 16

300000

Pixel Value

250000

200000
150000

100000
50000

□ Obese
■ Lean

i.k -

2&3

48.5

68.7

8&9

Lanes

108.11 12&13

VITA

Yibing W ang w as born on March 3 ,1 9 6 5 in Jinan, Shandong, China. After
graduating from Shandong Experimental Middle School in 1982, he attended
Shandong Medical University College of Medicine w here he obtained his
M.O. in 1987. Then he began graduate study in Shandong Medical
University with a Cardiology Fellowship from the Shandong Academ y of
Medical Sciences. At the sam e time he received his residency training in the
Departm ent of Cardiology at the Affiliated Hospital of Shandong Medical
University. He graduated in 1990 with a Master in Medicine. He w as then
enrolled in th e doctoral program in the Departm ent of Microbiology at
Louisiana S tate University in 1990. He pursued a graduate d eg ree in
G enetics under the direction of Dr. Braymer and upon completion of his
d eg ree requirem ents will receive a Ph.D. degree in the Departm ent of
Microbiology majoring in Genetics, minoring in Biochemistry.

155

DOCTORAL EXAMINATION AND DISSERTATION REPORT

Candidate:
Major Pield:

Yibing Wang
Microbiology

Title of Dissertation:

Binding of Hepatic Nuclear Proteins from Obese
and Lean Zucker Rats to the Upstream Region of
Malic Enzyme Gene
Approved:

EXAMINING COMMITTEE:

Date of Examination:
September 19, 1995

